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ABSTRACT 
The members of the bacterial class Mollicutes, commonly referred to as mycoplasmas have 
a number of unusual characteristics that make them difficult research subjects. These include 
complex media requirements, a lack of cell walls, a high genomic AT/GC ratio and frequently a 
non-standard translational system. In most orders of the Mollicutes, the codon UGA, a stop 
codon in the universal genetic code, codes for the amino acid tryptophan. As a consequence, 
standard genetic tools frequently do not function properly in these mycoplasmas. The focus of 
the research described here has been on the construction of two tools with wide applicability for 
future mycoplasmal research. The first is a derivative of transposon Tn4001, mini-Tn4001, that 
can be used to irreversibly insert a variety of markers into mycoplasmal chromosomes. The 
second is a derivative of the popular genetic marker, green fluorescent protein (GFP). The DNA 
sequence of this construct, designated GFPmyco was modified to reflect a mycoplasma coding 
usage pattern. The results of preliminary expression studies have confirmed that mini-
Tn400J tet is a functional mini-transposon in Mycoplasma gallisepticum and that GFPmyco can 
produce an observable fluorescent product in E. coli. Factors effecting GFP fluorescence and 
possible improvements in GFPmyco construction and expression are discussed. Both mini-
transposons and GFP markers have been extremely useful for both eucaryotic and non-
mycoplasma bacterial studies. It is hoped that these constructs, or their descendants, will be 
equally useful for the study of mycoplasmas. 
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INTRODUCTION 
In addition to lacking a cell wall, the bacterial class Mollicutes, commonly referred to as 
mycoplasmas have simple genomes and in most cases, a high genomic AT/GC ratio. Until 
recently, few researchers chose to work with mycoplasmas because of handling difficulties and 
the general lack of major human pathogenicity. Mycoplasmas are major economic factors in 
large-scale livestock production, and they may also impact public health, for example as 
secondary infections in human immunodeficiency disorders. As a result, there has been an 
upsurge of interest in mycoplasma research. 
While interest in mycoplasmas has increased, the technical difficulties of working with them 
remain. Mycoplasmas require highly enriched media, are difficult to manipulate genetically and 
have a nonstandard genetic code that makes the use of virtually any standard genetic tool 
problematic. Although mycoplasmas have smaller and less complex genomes, much less is 
known about essential mycoplasma functions and virulence mechanisms than the cellular 
activities of larger, but easier to manipulate Gram negative or Gram positive bacteria. 
The focus of the research described here has been on the construction of two tools with 
wide applicability for future mycoplasmal research. The first is a derivative of transposon 
Tn4001, mini-Tn4001, that can be used to irreversibly insert a variety of markers (including 
green fluorescent protein) into mycoplasmal chromosomes. The second is a derivative of green 
fluorescent protein (GFP) that has a mycoplasma-optimized coding usage pattern. This latter 
construct has been designated GFPmyco. 
Mobile genetic elements are powerful tools for the bacterial geneticist. One type of element, 
the transposon, has been used in a variety of ways including the identification of specific genes 
or gene control sequences. Transposons have been engineered to make them more useful by 
either adding useful features (reporter genes) or removing troublesome features. For example, 
to prevent multiple insertions of the transposon or its spontaneous excision, the transposase has 
been moved outside the element in some constructs. 
Only two transposons are known to function in mycoplasmas, Tn916 and Tn4001. 
Originally isolated from Gram positive bacteria, both have been used for transposon 
mutagenesis studies in mycoplasmas. However, either can undergo repeated and multiple 
insertions and/or excisions. The popular mini-transposon, mini-Tn5, was used as a model for 
the mini-Tn4001 construct. In the mini-Tn4001, the Tn4001 transposase gene has been shifted 
to a location on the plasmid outside the transposon. Transposition is only possible in the 
presence of the original plasmid sequences. Since the plasmid is unable to replicate in 
mycoplasmas , the transposase gene is quickly lost. The result is a stable, irreversible 
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chromosomal insert. The prototype mini- Tn4001 carries only a tetracycline gene for selection 
purposes, but other markers, such as the GFPmyco construct or other antibiotic resistance 
markers could easily be inserted. 
Green fluorescent protein has been used in a wide range of organisms to identify individual 
cells, subcellular locations of specific proteins and even follow protein-protein interactions. It 
also functions well as a fusion protein. While standard GFP genes might be translated in 
mycoplasmas, the differences in codon usage should prevent efficient translation of the message 
resulting in a low level fluorescent signal. In these studies we constructed a new GFP gene with 
the mycoplasma codon usage pattern using synthetic oligonucleotides and polymerase chain 
reactions. The amino acid sequence of the protein product is very similar to that of other 
popular GFP mutants, but it has a mycoplasma translation system optimized codon sequence 
and a mycoplasma promoter. 
The goal of this project was to produce two constructs that would be generally useful in 
mycoplasma research. Their application is beyond the scope of this project. However, it is 
expected that the first use of mini-Tn4001-GFPmyco constructs will be to examine the structure 
and control of invasion genes in M. gallisepticum. 
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LITERATURE REVIEW 
My co plasmas 
The term mycoplasma is commonly used to denote the class of cell wall-less bacteria in the 
class Mollicutes. Other characteristic features include small genome size (600-2200 kbp) and 
high genomic AT/GC ratios. The mycoplasmas are grouped into 4 orders and an undefined 
category. This last group is largely composed of a group of organisms previously referred to as 
mycoplasma-like organisms (l\1LO) of plants, now called Phytoplasmas. The major genera of 
the class Mollicutes are; Acholeplasma, Anaeroplasma, Asteroplasma, Spiroplasma, 
Enteroplasma, Mesoplasma, Ureaplasma and, of course, Mycoplasma (111). Most 
mycoplasmas are obligate parasites with narrow host ranges. While some are pathogenic, many 
are not. It is believed that they share a common ancestor with the Gram positive bacteria, and 
that the separation was evolutionarily recent. They are particularly close phylogenetically to AT 
rich Gram positive bacteria such as Bacillus subtilis (107) or Clostridium (14). 
Most mycoplasmas are not considered major pathogens in homo sapiens. Of the 150 
mollicute species of human origin listed in one review, only four or five are considered true 
human pathogens (143). Other species were found to be pathogenic only in individuals with 
immunodeficiencies (51, 143). In the mid 1990's there was a surge of interest in human 
mycoplasma infections as a result of apparent associations with AIDS and other immune 
problems such as Stevens-Johnson syndrome, an immune hypersensitivity disease. While 
mycoplasmas such Mycoplasma hominis and Ureaplasma urealyticum had long been 
associated with various diseases (23, 111, 143), a new highly cytopathic species, Mycoplasma 
penetrans, was isolated from AIDS patients. Another species, Mycoplasmafermentans was 
also frequently recovered from patients with AIDS, rheumatoid arthritis, immunosuppressive 
disorders and multistage oncogenic transformation (141). It was proposed that mycoplasmas 
might even cause a generalized low level immune suppression. While opportunistic 
mycoplasma infections are common in the immunosuppressed patient (97), no hard evidence 
has been found to support the theory that mycoplasma species actually serve as cofactors in 
HIV disease (11 , 12). Still these associations served to spur interest in mycoplasmal research. 
The effects of mycoplasma on livestock production are widely recognized. Although it is 
difficult to obtain exact figures, it is generally agreed that mycoplasmas are a major cause of 
economic loss in high intensity livestock and poultry production. Two of the most common will 
be discussed here, Mycoplasma hyopneumoniae and Mycoplasma gallisepticum. 
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Mycoplasma hyopneumoniae is endemic in American swine feedlots ( 117). It causes 
coughing, respiratory distress and frequently, pneumonia. The infected animals grow more 
slowly and finishing weights are reduced. The net result is reduced profits (117). It is also 
frequently associated with other major swine infections such as PRSSV (porcine reproductive 
and respiratory syndrome virus), an important problem in large-scale pig operations. Current 
vaccines offer only partial protection (118) . 
Mycoplasma gallisepticum is a major concern of the poultry industry. In the late 1980's it 
was estimated that U.S. mycoplasma-related egg production losses were over $95 million/year 
(15). Mycoplasma gallisepticum effects both egg production and bird profitability. It causes a 
chronic respiratory disease in chickens, turkeys and several other commercially marketed 
domestic poultry species (71). Like M. hyopneumoniae-infected swine (138), M gallisepticum-
infected birds are more susceptible to opportunistic (and possibly more serious) secondary 
infections, and dual infection is common. In the absence of a secondary infection, death is rare, 
but decreased hatchability, growth delays and lowered carcass quality all contribute to 
significant economic losses (71). It is obvious that organisms of such economic and health 
significance require further study. 
Characterization 
Probably the best known molecular property of mycoplasmas is the use of the codon UGA, 
normally a translational stop signal, to code for the amino acid tryptophan. This codon 
difference, which is also characteristic of mitochondria, is not found in all mycoplasmas. The 
phylogenetically early Acholeplasma and Phytoplasma use UGA as a stop codon (111, 154). 
Also, unlike mitochondria, the genomes of mycoplasmas do carry a tRNA n-p (CCA) gene. At 
this time the consensus is that these two incidences of identical abnormal codon usage are 
examples of convergent evolution. 
As previously mentioned, another defining characteristic of mycoplasmas is the unusually 
low G+C content of their genomes. For example, Mycoplasma capricolum has a G+C content 
of 25%, but the nucleotide distribution is not uniform. As might be expected, the non-coding 
regions are the most AT rich. Protein-coding regions are somewhat less so, and the highest GC 
content has been retained by the highly conserved tRNA and rRNA genes (50, 103, 104). 
The majority of the AT skewing appears to result from an underlying preference for A or T 
in the 3rd (wobble) codon position. This can be as high as 90% (103, 104, 152). The apparent 
AT preference is also reflected by amino acid usage frequencies (107). For example, the amino 
acids phenylalanine, isoleucine, asparagine and lysine are more prevalent in genomes with a low 
G+C content. There is an associated decrease in the amino acids proline, alanine, arginine and 
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glycine, all of which have codons with G and/or C in the first 2 positions ( 107). It is not known 
what causes this genetic drift in mycoplasmas and/or the G+C richness found in other bacterial 
species. 
AT biased directional mutation 
Codon usage is reflected by the tRNA gene pool. Probably the best studied is that of M. 
capricolum. As previously mentioned, the 1070 kilo base (kb) M. capricolum genome is only 
25% G+C (Yamao 1992). A detailed analysis showed that this genome carries only 29-30 
tRNA genes coding for 29 tRNAs (2, 102). In M. capricolum, there are groups of codons 
called family boxes for which the choice of amino acid is the same no matter what base is in the 
3rd position. These usually share 1 tRNA, which has the anticodon UNN, and translates all 
family members with equal frequency (68). For those amino acids coded for by a neighboring 
pair of codons, the tRNA is typically either GNN or *UNN (*U is a U derivative). These pair 
with both NNA and weakly with NNG. CNN pairs only with NNG. ANN tRNAs have not 
been found. Some tRNAs and their associated codons have actually been eliminated, e.g. CGG 
and the matching arginine tRNA codon CCG in M. capricolum. 
This dissection of apparent M. capricolum tRNA coding rules has also suggested a 
scenario for the alteration of a stop signal into a tryptophan codon in mycoplasma. Most 
mycoplasma carry two tRNA1rpgenes, one for the codons CCA and UCA and a separate one for 
the triplet UGA (a stop codon in the universal genetic code). In M. capricolum, this UGA 
tryptophan codon is actually translated more efficiently than the prototypical tryptophan codons 
and also occurs more frequently in the genome. In fact, the classic codon CCA is used for only 
10-20% of the tryptophan sequences. (153). 
According to this theory, the evolution of a codon goes through three stages. In the first 
stage as applied to mycoplasma, AT drift led to the preferential use of the more AT rich (in the 
first two bases) stop codons, UAA and UAG. Over time, the stop codon, UGA, was eliminated 
from the DNA sequence. Then a mutation occurred, producing a tRNA that could read UGA as 
a tryptophan codon. Continuing AT drift caused the replacement of most UGG tryptophan 
codons with UGAs. Eventually the tRN~ codon, CCA, may be entirely eliminated from the 
genome and/or evolve into another usage (152). 
Mycoplasmas offer more challenges to the researcher than the genomic differences 
described above. For example, they require complex media, precise growing conditions and 
careful handling (111). The lack of a cell wall makes them fragile and often polymorphic in 
shape. Their small sizes make them hard to visualize by light microscopy. They have few 
natural viruses and no native transposons. Their frequent role as secondary infectious agents 
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makes defining their unique attributes difficult. However, their economic and health importance 
will make it necessary to develop tools to overcome these barriers. 
Transposons and Transposon Mutagenesis 
Transposons 
Although credit for the discovery of transposable elements clearly belongs to Barbara 
McClintock who first observed them in maize over 50 years ago (93), no one individual can be 
credited with the discovery of bacterial transposable elements. In the early 1960's, Taylor (137) 
isolated what he referred to merely as a phage (Mu) that introduced a high rate of mutation in 
host Escherichia coli. In fact he was describing a virus-associated transposition system. The 
first characterization of bacterial IS elements did not take place until the late 1960's ( 45, 70, 
123). Work on more complex transposable units quickly followed (32, 113, 131), but the 
transposon now referred to as Tnl, i.e. the first discovered, was not described by Hedges and 
Jacob (62) until 1974. Transposable elements have now been found in Gram negative, Gram 
positive and archebacteria as well as higher eucaryotes. Mycoplasma-native transposons have 
not been identified. 
Transposons are grouped in families. Similarities in inverted repeat sequences, transposition 
mechanisms and transposases are used as classification criteria. Bacterial range is not. For 
example, there are a number of Gram positive members of the primarily Gram negative Tn3 
family (124). This suggests that there has been genetic recombination between Gram positive 
and Gram negative transposons (101). In fact, some transposons function both Gram positive 
and Gram negative organisms (146). Transposon families differ in insertional sequence 
specificities, e.g. AT-richness preferences, transposition immunity effects, cis-specificity of 
transposase activity and of course, transposition mechanisms. At this time genetic engineering 
has also produced many chimeric transposons, combinations of functional segments originally 
from different families (9). 
Mini-Transposons and transpositional mutagenesis 
Initially, complete transposons were used to generate insertional mutations for mapping 
and/or functional studies (9). A native transposon inserted into a genome may continue to 
transpose around the genome resulting in multiple insertions, and confusing or incorrect 
experimental data. This is particularly relevant when transposons are used in heterologous 
genetic systems. To combat this problem, mini-transposons were developed. They typically 
consist of a replication defective plasmid carrying an antibiotic resistance marker flanked by the 
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transposon's inner and outer inverted repeat sequences, and an adjacent transposase gene 
located outside the inverted repeats. The cis-acting transposase produced upon transformation 
acts on the inverted repeats by inserting them into the bacterial genome along with the resistance 
marker. The transposase gene remains on the plasmid, which is replication defective in the 
transformed host. The transposon is now trapped at the initial site of integration and without 
transposase activity cannot move to other locations. 
The usefulness of mini transposons has been well established. A large range of transposon 
derivatives have been developed including, mini-Tn5 (36, 66), mini-TnJ0 (48, 135), mini-Tn3, 
(67), mini-Tn7 (7), Tnl000 (10) and Mu (18) and various combinations thereof. These are 
common tools in both bacterial and eukaryotic experimental genetic systems. Most studies that 
employ mini-transposons fall into one of four categories; 1) identification of specific genes 
and/or their chromosomal localization 2) creation of fusion proteins for protein localization 
and/or expression studies 3) promoter studies, and 4) use as constitutively expressed cellular or 
organismal markers. The widely varying insertional specificities, species restrictions, etc. have 
necessitated the development of this battery of transposon derivatives. There are no mini-
transposon derivatives of the only two transposons known to function in mycoplasma, Tn4001 
and Tn916. 
The complexity of mini-transposons varies. The simplest (and smallest) is probably 
Tn5supF(l09). The selective marker for this transposon is the amber suppressor, supF, which 
is a gene that codes for a modified tRNA gene. The total size is 264 bp, and it was designed as a 
mutagen and for sequencing cloned DNAs in lambda phage. Because they can be modified so 
easily, the variety of these mini transposons is almost limitless. For example, Rode et al. 
inserted rare restriction sites into mini-TnJ O derivatives, which were then used for rapid 
mapping and comparisons of various E. coli strains ( 116). A large number of selectable 
markers or reporter genes have been used in these constructs. Antibiotic markers are most often 
used for selection, but other selective markers are readily available ( 109). Reporter genes have 
included lacZ, GFP (136) or other bioluminescent markers (20, 150). Such markers may carry 
their own promoters when being used for cell localization studies or for simple selection in 
culture. Promotorless markers are frequently used to construct mutations in gene control 
systems. Tang et al. used mini-Tn5-gfp-km, a bifunctional, promotorless construct to 
simultaneously select for insertion (viability on kanamycin-containing plates) and promoter 
expression levels under varying conditions (GFP fluorescence levels) in A. tumefaciens. Several 
pH sensitive promoters were identified. (136) . Such dual marker GFP- carrying Tn5 derivatives 
have also been used for cell morphology studies (79) or bacterial localization (151) . 
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Mini-transposon design has become quite sophisticated. An early model, the original 
TnMax mini-transposons (Tn1721 derivatives), carried antibiotic resistance or other 
(promoterless) marker genes for the identification of promoter signals (56). In the next 
generation of TnMax, M13 forward and reverse sequencing primers sequences were added to 
allow for easy sequencing of flanking host DNA (73). Other more sophisticated or specialized 
derivatives have followed. Recently Neuveglise constructed mTn Yl 1, a TnJ derivative with an 
antibiotic resistance marker for selection in E. coli, a selectable yeast marker (Ura3), a rare 
restriction site (Seel) to allow identification of the chromosomal insertion site, and a reporter 
gene (GFP) for creating translational fusions (105). The resulting construct is a new shuttle 
mutagenesis system for the yeast Yarrowia lipolytica. 
Mini-transposons are frequently used in the study of fusion proteins, intracellular 
interactions and regulatory systems. The rnini-transposon TnhlyA, which carries the secretion 
signal of the E. coli hemolysin Hly A, is used to produce fusion proteins that are secreted. This 
element has been used to determine the causes of variations in secretion level (52, 130). The bi-
cistronic reporter transposon rnini-Tn5 lacZ-tet/1 was used to identify E. coli operons that were 
activated by extracellular growth media from stationary phase cultures. The corresponding 
genes and their biochemical functions were then easily identified (6). 
Two other (sometimes overlapping) major research interests are regulatory pathway studies 
and virulence research. Ansaldi et al. used classic rnini-transposon insertion techniques to 
identify genes involved in the c-type cytochrome maturation pathway in E. coli (4). A similar 
system was used for virulence studies in Bruce/la suis. Bacteria were tagged with mini-Tn5 
km2, and avirulent (attenuated) mutants were identified. Mini-transposon flanking host 
sequences were used to assign functions to the associated genes (49). Mini-Tnl0 derivatives 
were used to identify the gene in a two gene operon coding for a critical virulence factor in 
Legionella pneumophila (145). 
Green fluorescent protein cassette-containing rnini-transposons have successfully been 
employed in a number of organisms, for example, yeast (105), marine bacteria (133), salmonella 
(21) and Helicobacter (72). These studies have produced variable results. Not all good 
promoters function equally well for GFP expression (72). Fluorescence can be media-
dependent, and in some systems there can be a high individual variation of GFP fluorescence 
( expression) within a single bacterial population. 
Transposons and mycoplasmas 
Although native transposable elements have not been identified in mycoplasmas ( even 
mycoplasmal viruses are rare), at least two Gram positive transposons are functional in 
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mycoplasmas, Tn916 and Tn4001 . Tn916, the first transposon found to be capable of 
transfonning mycoplasmas ( 41, 115), has been shown to be capable of transforming many 
mycoplasma species. However its large size, 18 kb, can cause difficulties such as reduced 
transformation efficiency, especially in some microorganisms (89). Its size is due to the 
complexity of its sequence, which includes conjugal functions. Also, Tn916 does not function 
in all mycoplasma species and cannot be used in some species because of tetracycline resistance 
problems. Tn4001 is a Gram positive transposon that encodes gentamicin resistance. It also has 
been shown to function in a number of mycoplasma species, and can also be used without 
concern for introduction of an antibiotic resistance that is of clinical significance. Because of its 
small size, Tn4001 was chosen for the parent for our mycoplasma-specific mini-transposon 
construction. 
Tn4001 
Tn4001 is a 4.7kb composite, class 1 transposon, first discovered in Australia during the 
investigation of a multi-antibiotic resistant outbreak of Staphylococcus aureus (85). It confers 
resistance to the aminoglycoside antibiotics, gentamicin, tobramycin and kanamycin. When the 
plasmid-based resistance gene was used in mixed culture experiments, resistant S. aureus 
isolates free of plasmid DNA were frequently produced. From this, it was concluded that the 
resistance gene was actually carried by a transposon (85). 
It is believed to be a young transposon. The first gentamicin-resistant S. aureus strains were 
isolated in 1970's (128, 129). Interestingly, the chromosomal insertion found on resistant S. 
aureus strains isolated in 1976 is 1.3 kb larger than that found in resistant strains isolated in the 
1980's. It has been suggested that the deletion of the 1.3kb section created an element small 
enough to be carried by a transposon. Direct repeats, typically due to duplication of flanking 
sequences during transposon insertion, are found in the plasmid resistance carrier, pSKl. In 
fact it is probably this transfer to a plasmid carrier that caused the observed increased incidence 
of antibiotic resistance. Sequence data supports the r~cent evolution of Tn4001. There is virtual 
sequence homology in the IS256 ends of multiple isolates. Long-separated populations should 
have acquired unique (silent) mutations over time (16). 
Although highly mobile in vivo, Tn4001 appears to have jumped to a plasmid carrier only 
once. Older resistant bacterial strains carry a chromosomal insert whereas more recently 
isolated strains tend to carry the plasmid-based version (53). A plasmid-based transposition-
defective version has also been found in North America and Europe (83). While the prototype 
source is the 27 kb plasmid pSKl, Tn4001 has also been found in a number of related 
plasmids. Since both transfer from plasmid to staphylococcal hosts and transposition within a 
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genome are extremely common in vivo, and the incidence of this resistance gene is high, it might 
have been expected that staphylococcus-to-plasmid transposition would also have been 
observed. This has not occurred, and no unrelated plasmid carriers have been identified. 
The structure of Tn4001 is well established. A 1.9 central portion carrying the resistance 
determinants is flanked by two 1.3 kb insertion sequence (IS) inverted repeats (IS256)(84, 85), 
which can also function as autonomous transposable elements (16). A 2.5 kb central HindIII 
fragment containing the antibiotic resistance marker and a portion of the IS256 repeats is 
frequently used for cloning modifications (53). Another 1.3kb TaqI/HincII fragment is also 
sometimes used in genetic manipulations of the central coding region. 
The 1,918 base pair (bp) central region has two open reading frames (ORFs), a 1,437 bp 
ORF which codes for the 56.9 kDa bifunctional antibiotic resistance protein and a 2nd smaller 
ORF. This second ORF does not appear to have translational initiation signals and may be 
nothing more than a vestigial gene fragment ( 16). Several potential promoters 5, to the coding 
sequence of the first ORF have been identified, with those named Pl and P2 considered the 
most important. 
As usual, the IS elements code for the transposase gene. Each 1,324bp IS256 element has a 
single ORF. This large 390 amino acid ORF codes for the transposase gene, designated tnp. It 
is preceded by a potential Shine Dalgamo ribosomal binding site and -35 and -10 promoter 
sequences. Transposition is controlled by transposase concentration, which in turn is regulated 
by a combination of weak promoters and/or antisense RNA produced from a highly active 
promoter P our. No apparent homology with other transposase genes has been found. Like many 
other IS elements, IS256 has 26 bp imperfect terminal inverted repeats, which in this case, have 
a 17 bp match (16). 
The G+C content of the antibiotic gene coding region (-24% G+C) is very different from 
that of the IS256 elements (-36% G+C), and quite uncharacteristically low for a S. aureus 
sequence. This data supports the cassette assembly model of transposon Tn4001 construction, 
i.e. an antibiotic resistance gene was captured from an organism in another genera (16, 120). 
Enzymatic activity 
While enzymatic modification is characteristic of antibiotic resistance, typically a single 
enzyme product of a single gene acts upon a unique antibiotic. The enzyme carried by Tn4001 
is an exception. Of the three major types of arninoglycoside resistance enzymatic activities, 
arninoglycoside-O-phosphotransferase (APH), aminoglycoside-N- acetyl transferase (AAC) 
and arninoglycoside-O-adenyltransferase (AAD), Tn4001 carries two, a 6'-acetyltransferase 
[AAC(6')] and a 2'-phosphotransferase [APH(2")]. The protein actually is a 56.9 kDa bi-
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functional protein with two enzymatic domains. The 5' end (167-80 codons) codes for the aacA 
gene for tobramycin and kanamycin resistance while the carboxy terminal end encodes for the 
APH gene, aphD for gentamicin resistance (120). Deletion mutation studies have shown that 
while the 5' end can function in the absence of the 3' end, most of the 5' end is required for 
APH activity (120). 
Although useful as a genetic tool, Tn4001 has not been used in many transposition studies 
as, for example, Tn916. Previous researchers listed the advantages of using Tn4001 in Gram 
positive hosts. They include easily selectable phenotype, multiple chromosomal insertion sites, 
ability to manipulate chromosome adjacent to sites of interest and capability of precise excision. 
Less positive characteristics were also listed: instability at any one site (high reversion 
frequency), insertion hot spots, and the possible requirement for a recombination deficient host 
to negate a homologous recombination effect for efficient recovery (75). Not all of these 
negative features may be operative when mycoplasmas are used as the recipient. 
In 1989, Mahairas and Minion used a pSKl derivative, pISMlOOl, to introduce Tn4001 
into Acholeplasma oculi (86, 88). It was found to form stable integrants and be 
transpositionally active. Probably the most frequent use of Tn4001 has been for mapping. It has 
been used to map S. aureus (87), Acholeplasma oculi 1499 ( 140), and M. gallisepticum ( 17, 
139). A rare restriction site was inserted in the transposon to facilitate mapping,. 
Tn4001 derivatives have also been used in several studies of promoter probes in 
mycoplasmas. Initially, two restriction sites, SmaI and BamHI, were placed 26 bp from one end 
of the transposon within the IS256 element to create Tn4001mod (75). This construct was used 
to deliver wildtype genes in M. pneumoniae to complement chromosomal mutations (57). The 
same sites were used for the rare restriction site insertions for the chromosomal physical 
mapping studies (140). Upstream stop codons in each of the reading frames were removed by 
site directed mutagenesis to create a protein fusion vector using ~-galactosidase as the reporter 
gene (75). Other reporter genes have also been used (tetM and phoA)(95). Another construct, 
Tn4001 .2065, was constructed with a plasmid origin of replication and a selectable marker 
within Tn4001 to allow for the direct rescue of chromosomal sequences adjacent to the insertion 
site (75). These derivatives of Tn4001 can be used for a variety of studies in mycoplasmas, but 
independent transposition of the IS256 elements and other features that limit their usefulness. 
Adherence is an essential component of mycoplasma infectivity. Recently, Tn4001 was used 
for complex studies of mycoplasma adherence proteins. Hedreda and Krause used 
transposition mutagenesis to identify adherence gene regulatory sequences in M pneumoniae 
(63, 77). Almost incidentally, their experiments also established that a previously identified 
major adherence protein was actually a dimer of another protein ( 46, 77). 
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Researchers have only begun to explore the experimental potential of Tn4001. In addition to 
its original host staphylococcus and various mycoplasmas, it has shown promise in 
Streptococcus gordonii transposition mutagenesis studies (82). Other transposons, such as 
Tn916, have been shown to have extremely wide host ranges, and it is possible Tn4001 or its 
derivatives will be useful in other bacterial hosts. The development of one such tool is the focus 
of this work. 
Green Fluorescent Protein 
Uses 
Since the discovery that the green fluorescent protein (GFP) of Aequorea victoria can be 
expressed in heterologous organisms (19), it has become a widely used molecular and cellular 
research tool. It has been visualized in bacteria (91), yeast (40), Drosophila (43, 44), human cell 
lines (156, 157), various plants and many other higher eucaryotes. A partial list of uses might 
include: labeling single cells, labeling organelles within cells, identifying changes in organelle 
pH, cell sorting, and studying individual protein-protein interactions. These are discussed in 
more detail below. 
The most common use of GFP is as a marker for gene expression. Sometimes GFP 
functions as a reporter gene for protein production where it replaces such standbys as lacZ 
fusions or antibody labeling. The original Chalfie studies on a subpopulation of neuronal cells 
in the nematode Caenorhabditis elegans clearly demonstrated the biological equivalence of 
antibody and GFP gene fusion labeling, at least in their system (19). It has also been used for 
more basic studies on gene expression mechanisms. 
GFP tagging has become a standard technique for protein localization studies. Chalfie et al. 
stated that native GFP is primarily localized in the cytoplasm, but it may also diffuse into the 
nucleus (19). By attaching various signal sequences, GFP can be targeted to specific organelles 
(35) or the cellular membrane (100). Since fixation is not required for GFP visualization, it can 
be used to monitor organelle changes in vivo. One particularly elegant example is the work on 
nuclear localization signals and nucleus-cytoplasm protein shuttling in yeast by Lee et al., but 
there have been many other studies (78). 
Many recent studies of the cellular cytoskeleton have used GFP as a marker. Endow and 
Komma used a linked ncd-gfp construct (Ned is a microtubule motor protein) to visualize 
mitotic spindle attachment and assembly in Drosophila oocytes and embryos (43, 44). GFP-a-
actinin, GFP-titin, and GFP-myosin are currently being used to deconstruct the actin/myosin 
cytoskeleton activities of living muscle cells (31). It can even be used to mark specific 
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chromosomal segments. In vivo expression of GFP-lac-repressor fusion proteins binding to 
previously introduced lac operator sequences cloned into CHO or yeast chromosomal DNA 
has been used to study chromosomal structures in situ (8, 132). 
One of the most exciting new uses for GFP is in the study of protein-protein interactions. 
FRET (fluorescence resonance energy transfer) is a technique that uses two fluorophores (light 
emitting proteins), one donor and one acceptor, to measure the distance between the two. In 
simplest terms, two potentially interactive proteins are each tagged with a different fluorophore 
i.e. a GFP variant. UV excitation causes the donor protein to emit energy at the optimal 
excitation wavelength for the second tag. The amount of energy absorbed by this second protein 
tag (and therefore the amount of energy it emits as fluorescence) is proportional to the distance 
between the two proteins. The latest technique, PRIM (34) uses the formation of GFP dimers 
by two GFP tags and the associated emission spectra wavelength shifts to monitor the 
proximity of the proteins of interest. Although use of GFP has exploded in recent years, 
researchers have just begun to develop new techniques that utilize its unique properties. 
Properties 
Green fluorescent protein is a 238 amino acid fluorescent protein. It has two absorbance 
peaks, the major one at 395 nm and a minor one at 475 and a single emission peak at 508nm 
(69, 148). Like other green fluorescent proteins, it is one of a pair of chemiluminescent proteins. 
In Aequorea the other protein is aequorin, In the presence of Ca2+ in vivo, aequorin emits 
chemiluminescence with a peak around 470 nm, near the absorbance maximum of GFP. This in 
tum causes GFP to emit at 508nm producing the green fluorescence observed in vivo. In the 
absence of GFP, aequorin fluorescence is blue. 
The 3d structure of GFP is the prototypical ~ barrel or ~ can consisting of 11 anti parallel ~ 
sheets arranged in a cylindrical shape with caps of a helix at each end. The barrel has a 
diameter of 25-30A and a length of about 40A. An irregular a helical strand positions the 
chromophore (amino acids 65-67) near the center of the hollow barrel (155). This unusual, 
highly protective structure is conserved in all functional GFP mutants that have as yet been 
studied, such as the popular S65T mutant (106). Amino acids 2-229 are required for activity 
(39). Unlike other GFP proteins, e.g. that of Renilla the sea pansy, which are obligate dimers, 
the Aequorea GFP protein molecule can function as a monomer in dilute solution, although it is 
believed to function as a dimer or as an aequorin2 - GFP2 heterotetramer in vivo (30). 
The chromophore is formed by the cyclization of S65Y66G67 into an imidazolone 5-
member ring. It is currently believed that the chromophore is formed in three steps; 3D 
structure formation, cyclization, and finally, oxidation of the hydroxybenzyl side chain of Y66 
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(22, 65). While most authors believe that the oxidation is the slow (2-4 hours) rate-limiting step 
(112), studies on thermal mutants have suggested that, in some cases, folding may be the rate-
limiting step (126). 
As previously mentioned, wild type GFP has two absorbance peaks, one at 375 nm and one 
at 495 nm. The ratio of these two peaks is strongly affected by reaction conditions. Increases in 
pH, temperature, ionic strength, protein concentration (29, 147, 149) decrease the relative size of 
the 37 5 nm peak. Part of this shift may be due to changes in spectral properties resulting from 
dimerization. Of course, mutation is another source of spectral differences (37, 64, 65). 
The expression "wild type green fluorescent protein" (WT-GFP) is generally used for 
proteins with a DNA sequence that matches that of the GFP cDNA first cloned and sequenced 
in 1992 (110). In fact that clone included an inadvertent (functionally silent) PCR artifact, 
E80R. Even at that time, there was evidence that there are a number of GFP isoforms in the 
jellyfish population. Some are the products of multiple GFP genes or alleles with point 
mutations while other isolates may be artifacts, as the carboxyl end of the protein is highly 
susceptible to proteolytic cleavage (29). 
Background 
Green fluorescent protein was first discovered by Shimomura et al. in the early 1960's 
during studies on aequorin, the primary luminescent protein of Aequorea (125). As previously 
mentioned, they observed that purified aequorin produced blue fluorescence, but the 
fluorescence of Aequorea in vivo is green. Another protein in their impure aequorin protein 
preparations was the source of the green fluorescence. This protein was called "green 
fluorescent protein". Two years later, the same group published the spectra of both aequorin 
and GFP (69), but it was not until 1974 that Morise et al. actually proved that aequorin could 
directly transfer its luminescence energy to GFP (99). The exact mechanism of the aequorin-
GFP energy transfer has still not been definitively established. It was not cloned and sequenced 
until 1992 (110). 
The source of GFP, the jellyfish, Aequorea victoria, is a curved, transparent, lens- shaped 
creature with fringed edges about 7-10 cm in diameter. The fluorescence pattern is striking. 
While the center of the body is largely invisible, a disk (the outer margin) has green fluorescent 
stripes radiating inward from approximately 200 spots on the outer edge (the photogenic 
organs). Each photogenic organ has 6-7000 photogenic cells (33). 
A number of other coelenterates also contain green fluorescent proteins (25, 61 , 98). The 
best studied of these is the sea pansy, Renilla. Most have the same core chromophore and 
emission spectra, but not the same absorption spectra, DNA sequence or 3D structure. All seem 
15 
to employ the same basic scheme, requiring excitation by a primary chemiluminescent protein. 
They differ from Aequorea GFP in two important ways. They require external cofactors for 
chromophore formation, and they are obligate dimers (148). Aequorea victoria is the only 
known source of non-cofactor-requiring GFP. Recently, Matz isolated several other fluorescent 
proteins homologous to GFP from Discosoma species (92). These proteins also appear to be 
cofactor-independent and have the same~ can structure as GFP, but they fluoresce at very 
different wavelengths. In this paper, as in most studies, the term green fluorescent protein or 
GFP will refer to the Aequorea product unless otherwise specified. 
In 1994 Chalfie et al. discovered two interesting facts. GFP could be expressed in 
heterologous organisms, i.e. E. coli and C. elegans when spliced to organism-specific 
promoters, and the cellular distribution of these proteins would mimic that of the promoter used 
( 19). Two attributes transformed Aequorea green fluorescent protein from an obscure research 
subject into a major molecular biology tool. 
1. No external cofactors are required for its activity. 
2. It can be expressed in virtually any organism ( 19). 
Characteristics of GFP as a research tool 
There are a number of features that make GFP particularly useful. Once the chromophore 
has folded, the protein is very stable. The folded protein is highly resistant to proteases, (13, 
119), anionic and non-anionic detergents (54), fixatives ((19) and changes in pH (147), 
although very high pH may change the 470 nm/395 nm absorbance ratio. The folded protein is 
temperature resistant (Tm=76°C)(13). Refolding and activity are usually recoverable even after 
harsh denaturing conditions. The fluorescence is unaffected by many cellular fixatives. While 
wild type GFP also has a few less desirable characteristics. 
1. Complex folding is required to form the chromophore and it does not fold well at 37°C 
(80, 142) even though, once folded it is temperature resistant. 
2. The folding process is slow 2-4 hours (64, 65), and a significant proportion of the 
molecules never fold. This makes its use in real-time in vivo gene studies difficult. 
3. The fluorescence signal (which is not amplified in the system) is not very bright and 
may be masked by cellular autofluorescence. 
4. The optimal codon usage for jellyfish is not that of other species. 
The design of mutant GFP proteins has been a major area of study in the past few years. 
Researchers have generally focused on increasing brightness, spectral shifting, and/or 
optimizing codon usage. In the process they have isolated or designed temperature resistant 
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and/or faster folding mutants, various red, blue and yellow fluorescent proteins, and clones with 
prokaryotic, human ( or mammalian) and plant optimized sequences. 
Probably the greatest interest has been in color-shifted mutants. The chromophores of 
Renilla and Aequorea GFP are identical, yet the single excitation peak of Renilla GFP is at a 
much more experimentally useful wavelength than that of Aequorea ( 498 nm vs 395 nm and 
475 nm in Aequorea). Aequorea GFP mutants with Renilla GFP-like spectral qualities would 
be ideal. When Heim et al. first subjected a GFP cDNA library to random mutagenesis, they 
found a number of GFP variants, most with mutations in the C terminal region (65). Delagrave 
et al. used site directed mutagenesis of the 6 amino acid region surrounding the Aequorea GFP 
chromophore and screened the resulting clones for red shifted variants (RSGFP)(37). Several 
of their (multiple site) mutants had the desired spectral shift. The results of both studies seemed 
to suggest that changes in the chromophore microenvironment can cause in major modifications 
in absorbance spectra 
Major absorbance shifts can also be produced by simple amino acid substitutions in the 
chromophore itself. Each amino acid position of the chromophore has unique requirements 
(28). While there seems to be an absolute requirement for G67, Y66 can be replaced by virtually 
any aromatic side chain. The less electron-rich the side chain, the more blue-shifted the spectra. 
Phenylalanine is the least electron rich, followed by histidine, tryptophan, and the charged form 
of tyrosine found in the wild type sequence. The corresponding GFP excitation peaks are 382 
nm for Y66H, 433 nm for Y66W and 475 nm for the charged, wildtype Y66. The uncharged 
tyrosine emission peak of wildtype is at 395 nm. The emission peaks of the GFP variants, 
Y66H (488 nm) and Y66W (485 nm), are equally blue-shifted when compared with the 504 nm 
peak of the Y66 wild type, charged tyrosine. The blue-shifted mutants produce significantly 
lower levels of fluorescence than wild type. The blue-shifted proteins are commonly referred to 
as blue fluorescent proteins (65), a term which unfortunately has also been used for activated 
aequonn. 
Changes in serine 65 (small aliphatic amino acids required) are associated with longer (red) 
wavelength shifts. Probably the best known is S65T which has a single red-shifted absorbance 
peak with a maximum of 490-510 nm (64), but not all red-shifted mutants carry an S65 
mutation (37). There are now also yellow mutants (YBP). The spectral range of GFP mutants is 
now so great that mutants with differing absorbance and emission spectra can be used to label 
and differentiate between two proteins or structures in the same cell (114). This was first 
demonstrated by Heim et al. who used changing fluorescence patterns to follow trypsin 
digestion and the associated loss of dimerization of a GFP-BFP chimera (64). Excited BFP was 
used to excite neighboring GFP (64). Color mutants have different uses, i.e. red shifted mutants 
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are good for FACS (flow activated cell sorting) but are hard to see with a fluorescence 
microscope. Mutants may also have different fluorescent lifetimes. Pepperkok et al. recently 
individually visualized four co-expressed GFP variants using fluorescence lifetime imaging 
microscopy (108). 
Most folding mutations have been isolated indirectly. In many cases so called brighter 
mutants were actually faster folding mutants. Siemering et al. compared cellular fluorescence 
levels with cellular GFP protein concentrations and found that this ratio (which decreases with 
temperature) is greater in their bright mutant GFP A ( 126). The apparent thermo-tolerance is due 
to improved folding not increased oxidation rates. One of the reasons that the mutant S65T has 
become so popular is that it folds approximately 4 times faster than wild type, 45 min vs 2 
hours under the conditions used in Heim et al. 1995 (64). When Cormack et al. used FACS 
sorting to select for increased fluorescence, they also isolated S65T mutants (24 ). Many folding 
mutations are far from the chromophore. V 163A is a folding mutant that has been 
independently isolated several times. Amino acid 163 is believed to be an important contributor 
to a folding intermediate since the presence of V163A in virtually any mutant decreases folding 
time (126). Another mutation S 147P greatly improves GFP folding at 37°C but not at 23°C 
(74). 
Until recently, most studies have utilized the great stability of folded GFP. However this can 
be a disadvantage for real-time protein-protein or protein-organelle studies. Several unstable 
variants of GFP with C-terminal extensions that are highly susceptible to degradation have been 
constructed (3) and are now commercially available (Clontech). 
The third area of GFP mutation development focus is species-specific codon optimization. 
While GFP expression has been possible in virtually all organisms tried, in many cases the wild 
type gene produces low or non-detectable levels of protein. One of the most extreme examples 
of this is Arabidopsis where a region of the wild type GFP sequence mimics an Arabidopsis 
splice signal causing a 84bp deletion in the protein product found in these plants (60). Some 
researchers have used strong promoters to increase protein production and compensate for low 
expression or poor fluorescence signals (114, 134, 144). Others have turned to codon 
optimization systems. 
Optimized variants have been produced for Arabidopsis (60), humans (55, 157) and E.coli 
(26). The last two are commercially available as GFPuv and EGFP respectively (Clontech), and 
have been successfully used in a variety of bacteria, mammals and some plants. 
At this time there has been only one published account of GFP use in mycoplasma 
research. Dhandayuthapani et al. used it to retrieve certain promoter sequences from a 
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mycoplasma cDNA library (38). Since in this study the GFP marker was expressed only in E. 
coli, the question of GFP expression in vivo in mycoplasma was not addressed. 
As the field of GFP research matures, the focus is shifting from mutant construction and 
characterization towards sophisticated applications in cell and molecular biology and 
experimental results. However, there are still cases in which GFP modification must be the 
preliminary step in an experimental sequence. The construction of a mycoplasma-specific GFP 
mutant discussed in this paper is one such step. 
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MATERIALS AND METHODS 
Bacterial Strains and Plasmids 
The bacterial strains used in this study are listed in Table 1. Bacteria were maintained at 
-70°C. E.coli strains were grown in Luria-Bertani Broth, Super Broth or SOC broth (122) . M. 
gallisepticum strain Rand M. pulmonis strain UAB6510 were maintained in PPLO 
mycoplasma media (25 gm per L, 0.2 gm per L herring sperm DNA, 15% donor herd horse 
serum, 5% fresh yeast extract, 0.5% w/v glucose, and 2.5 mg per L Cefobid) (94). 
Acholeplasma oculi 1499 was maintained in the same medium except that agamma horse serum 
(Gibco BRL) was used. For solid agar, Noble agar was added at 1 % prior to autoclaving the 
base. Table 2 describes the plasmids used in these studies. Plasmids were stored at either -20°C 
or -70°C. Oligomers used in these studies are listed in Table 3. 
Table 1. Bacterial strains. 
Strain Description Source 
E.coli 
LE392 ~ hsdR514 (rk-, mk-) lacYJ supE44 supF58 ga!K2 (58) 
galT22 trpR55 metBJ, ').,,-
TOPlO F- mcrA !i(mrr-hsa RMS-mer BC) <P80lacZ/iM15 Invitrogen 
!ilacX74 deoR recAJ araD139 !i(ara-leu)7697 galU 
ga!K rpsL endAJ nupG; pZerO2 cloning host 
ISM614 LE392 pISM3001; used for expression of GFP (127) 
ISM1246 LE392 pISM1238 (pISM2062.2:GFPuv) This study 
ISM955 LE392 pGFPuv This study 
Mycoplasma 
M. gallisepticum virulent strain R F.Goff 
A. oculi 1499 (5) 
M. pulmonis virulent strain UAB6510 G. Cassell 
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Table 2. Plasmids. 
Plasmid 
pZerO2 
pGFPuv 
pSK-
pISM27 
pISM28 
pISM29 
pISM30 
pISM31 
pISM32 
pISM33 
pISM34 
pISM35 
pISM36 
pISMlO0l 
Genotype or phenotype 
positive selection cloning vector, CmR 
source of GFP gene, KanR 
cloning vector, AmpR 
pSK- containing outer repeat of Tn4001 
pISM27 containing inner repeat of Tn4001 
pISM28 and transposase of Tn 4001; mini-Tn4001, 
AffipR 
P2GFPmyco in pISM2062, AmpR· GmtR 
mini-Tn400ltet, AmpRTetR 
GFPmyco in pSK, AmpR 
5' end of GFPmyco gene in pZerO2, CmR 
3' end of GFPmyco gene in pZerO2, CmR 
GFPmyco in pISM2062.2 
GFPmyco in pISM2062.2 (reverse orientation) 
contains Tn4001, primer for transposase gene PCR, TetR 
pISM 1002 primer for tetM gene PCR, TetR 
pISM2050.2 primer forP2 promoter PCR, AmpR, GmR 
pISM2062 cloning vector, contains Tn4001 mod, Amp\ GmR 
Source 
Invitrogen 
Clontech 
Stratagene 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
(88) 
(87) 
(76) 
(75) 
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Table 3. Primers. 
Name Function Sequence (5' -3' ) 
TNI2- IS256 inner repeat CAGTCAAGTCCAGACTCCTGTGTAAAAA 
sequence 
TNI2+ IS256 inner repeat CTAGTTTTTACACAGGAGTCTGGACTTGA 
sequence CTGAGCT 
TNO- IS256 outer repeat CCCCGAATTCTTTTACACAATTATACGGA 
sequence CTTTATCAACAAGCTTACCC 
TNO+ IS256 outer repeat GGGTAAGCTTGATAAAGTCCGTATAATTG 
sequence TGTAAAAGAATTCGGGG 
TNPR2 Transposase PCR GGGTGGTACCCCATTTCTACTTATC 
primer 
TNPL3 Transposase PCR GGGTGTCGACGTGTAAAAGTAAAAAGGCC 
primer 
IS256 sequencing GGAAATGTATGTATCAGGCG 
CM3F Construction of ATGGATCCATGAGTAAAGGTGAAGAATTA 
GFP-1 TTTACAGGTGTAGTACCAATTTTAGTTG 
CM4F Construction of AATTAGATGGTGATGTTAATGGTCATAAA 
GFP-1 TTTAGTGTAAGTGGTGAAGGTGAAGGTGA 
TG 
CM5F Construction of CAACATATGGTAAATTAACATTAAAATTT 
GFP-1 ATTTGTACTACTGGTAAATTACCAGTACC 
AT 
CM6F Construction of GACCAACTTTAGTAACAACTTTTGGTTAT 
GFP-1 GGTGTACAATGTTTTGCTAGATATCCAGA 
TC 
CM7Fb Construction of CTAGATATCCAGATCACATGAAAAGACAC 
GFP-2 GA I I I I I I I AAAAGTGCTATGCCAGAAGG 
TT 
CM8Fb Construction of ATGTTCAAGAAAGAACAATTAGTTTTAAA 
GFP-2 GATGATGGTAATTATAAAACAAGAGCAGA 
AG 
CM9R Construction of CACCTTTACTCATGGATCCAT 
GFP-1 
CMl0R Construction of GACCATTAACATCACCATCTAATTCAACT 
GFP-1 AAAATTGGTACTACACCTGTAAATAATTC 
TT 
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Table 3. Primers (Continued) 
CMllR Construction of TTAATGTTAATTTACCATATGTTGCATCAC 
GFP-1 CTTCACCTTCACCACTTACACTAAATTTA 
T 
CM12R Construction of CAAAAGTTGTTACTAAAGTTGGTCATGGT 
GFP-1 ACTGGTAATTTACCAGTAGTACAAATAAA 
TT 
CM13R Construction of GATCTGGATATCTAGCAAAACATTGTACA 
GFP-1 CCATAAC 
CMl4F GFP-1 PCR ATGGATCCATGAGTAAAGGTG 
primer 
CM15R GFP-1 PCR GATCTGGATATCTAGCAAAAC 
primer 
CM16F Construction of TAAAATTTGAAGGTGATACTTTAGTAAAT 
GFP-2 AGAATTGAATTAAAAGGTATTGATTTTAA 
AG 
CM17F Construction of AAGATGGTAATATTTTAGGTCATAAATTA 
GFP-2 GAATATAATTATAACAGTCATAACGTTTA 
TA 
CM18F Construction of TTACTGCTGATAAACAAAAAAATGGTATT 
GFP-2 AAAGCTAATTTTAAAATTAGACATAACAT 
TG 
CM19F Construction of AAGATGGTAGTGTTCAATTAGCAGATCAC 
GFP-2 TATCAACAAAATACTCCAATTGGTGATGG 
TC 
CM20F Construction of CAGTTTTATTACCAGATAATCATTATTTAA 
GFP-2 GTACTCAAAGTGCTTTAAGTAAAGATCCA 
A 
CM21F Construction of ATGAAAAAAGAGATCACATGGTATTATTA 
GFP-2 GAATTTGTAACTGCTGCTGGTATTACTCA 
CG 
CM22F Construction of GTATGGATGAATTATATAAATAAGAATTC 
GFP-2 GCTG 
CM23R Construction of CAGCGAATTCTTATTTATATAATTCATCCA 
GFP-2 TACCGTGAGTAATACCAGCAGCAGTTACA 
A 
CM24R Construction of ATTCTAATAATACCATGTGATCTCII I I I I 
GFP-2 CATTTGGATCTTTACTTAAAGCACTTTGAG 
CM25R Construction of TACTTAAATAATGATTATCTGGTAATAAA 
GFP-2 ACTGGACCATCACCAATTGGAGTATTTTG 
TT 
CM26R Construction of GATAGTGATCTGCTAATTGAACACTACCA 
GFP-2 TCTTCAATGTTATGTCTAATTTTAAAATTA 
G 
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Table 3. Primers (Continued) 
CM27R Construction of CTTTAATACCAIIIIIIIGTTTATCAGCAG 
GFP-2 TAATATAAACGTTATGACTGTTATAATTAT 
CM28R Construction of ATTCTAATTTATGACCTAAAATATTACCAT 
GFP-2 CTTCTTTAAAATCAATACCTTTTAATTCAA 
CM29R Construction of TTCTATTTACTAAAGTATCACCTTCAAATT 
GFP-2 TTACTTCTGCTCTTGTTTTATAATTACCAT 
CM30R Construction of CATCTTTAAAACTAATTGTTCTTTCTTGAA 
GFP-2 CATAACCTTCTGGCATAGCACTTTTAAAA 
A 
CM31R Construction of AATCGTGTCTTTTCATGTGATCTGGATATC 
GFP-2 TAG 
CM32F GFP-2 PCR CTAGATATCCAGATCACATGAAAAGAC 
primer 
CM33R GFP-2 PCR CAGCGAATTCTTATTTATATAATTCATCC 
primer 
GFPmy.seq sequencing AAAGTGCTATGCCAGAAGGTTATGTTC 
AcP2R PCR of P2 CTTATCACTCCAAATAATCTTATACTTTTT 
promoter ATA 
AcP2F PCR of P2 TTGGATCCGTCTTGGATGAAGTCTTAAAG 
promoter CAC 
GFPmyF Forward primer for ATGAGTAAAGGTGAAGAATTATTTACAGG 
GFPmyco TGTA 
CM33R.Bam Reverse primer for CAGCGGATCCTTATTTATATAATTCATCC 
GFPmyco 
GFPmyR Reverse primer for TAGGATCCTTATTTATATATAATTCATCCA 
GFPmyco TACCGTG 
THI I I bla specific primer TTATCCGCCTCCATCCAGTC 
TH112 bla specific primer TGGGTGCACGAGYGGGYYAC 
tetM. l tetM specific CCCATTATTAATATTGGAGTTTTA 
primer 
tetM.2 tetM specific CCCTTATATAACAACTTAAATTACACTA 
rimer 
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Reagents and Buffers 
Restriction enzymes, 1 kb plus molecular weight ladder, and proteinase K were obtained 
from Gibco BRL (Gaithersburg, Md.), New England Biolabs (Beverly, Maine), or Promega 
Corporation (Madison, Wis.). Calf intestinal alkaline phosphatase was obtained from Qiagen, 
and Pfu DNA Polymerase from Stratagene (La Jolla, Calif.) or Promega. Agarose was 
purchased from Bio-Rad Laboratories (Hercules, Calif.) or FMC Bioproducts (Rockland, 
Maine), isopropyl thio-B-D galactoside (IPTG) from Gold Biotechnology, Inc. (St. Louis, 
Mo.). PCR grade water (Gibco-BRL) and deoxynucleotides (Amersham Pharmacia, 
Piscataway, N.J.) were used in PCR reactions. Dry media components were obtained from 
Difeo, horse sera from Gibco-BRL, and Cefobid from Pfizer (New York, N.Y.). Other 
chemicals were obtained from Sigma Chemical Co. (St. Louis, Mo.). A Zero Background/Kan 
Cloning Kit (Invitrogen, Carlsbad, Calif.) was also used. 
A Peltier Thermal Cycler PTC-2000/PTC225 (MJ Research, Watertown, MA) was used for 
polymerase chain reactions (PCR). An Olympus microscope was used for UV fluorescence 
studies. Confocal microscope studies were done at the Iowa State University Image Analysis 
Facility using a Leica TCS-NT Confocal Microscope (Leica Microsystems, Inc., Exton, Penn.). 
DNA Manipulations 
The strategies used for the assembly of constructs were straightforward. DNA was obtained 
from E.coli using an E.N.Z.A Plasmid Miniprep Kit II from Omega Biotek (Norcross, Ga.) or 
Qiagen plasmid Midi Kits (Santa Clarita, Calif.). In some cases, PCR products were purified 
from agarose gels using a QIAquick PCR Purification kit (Valencia, Calif.). Sequence data (1) 
were used to design oligonucleotides to match the region(s) of interest. Oligonucleotide primers 
were designed using Oligo 5 software (National Biosciences, Inc, Plymouth, Minn.) and 
synthesized at the Iowa State University DNA facility using a DNNRNA Synthesizer (Model 
399, Applied Biosystems, The Perkin-Elmer Corporation, Norwalk, Conn.).These 
oligonucleotides were used to construct GFPmyco gene segments or as PCR primers. The 
DNA product(s) were then ligated into the appropriate vectors. The resulting constructs were 
transformed into E coli and grown on the appropriate selective media. The resulting putative 
clones were digested with restriction enzymes, and the fragments were analyzed on agarose gels 
to determine the restriction pattern of the insert. Those clones with the expected restriction 
pattern were sequenced to confirm that no base pair changes had been introduced during PCR. 
25 
All DNA sequencing was done at the Iowa State University DNA Sequencing Facility using 
cycle sequencing protocols and an automated DNA sequencer (Applied Biosystems, The 
Perkin-Elmer Corporation). The data were edited and assembled using Factura, AutoAssembler 
and Sequence Navigator (Applied Biosystems, The Perkin Elmer Corporation). Mac Vector 6.0 
(Eastman Kodak Company, Rochester, N.Y.) was used for in-lab sequence analysis. After 
assembly, the constructs were tested for expression by transformation into E. coli (122) and in 
mycoplasmas by electroporation (96) where appropriate. 
Transformation 
To prepare electrocompetent E. coli, 500 ml of LB were inoculated with 10 ml of an 
overnight broth culture of E.coli and grown at 37°C with shaking until the O.D.6()()= 0.4- 0.7. 
After chilling on ice for 20 minutes, the cells were centrifuged at 6-7,000 x g for 10 minutes at 
4 °C and resuspended in 500 ml of sterile, chilled Super Q water. After a 10 minute incubation 
on ice, the cells were centrifuged as before, resuspended in 250 ml cold water, incubated on ice 
for 10 minutes and centrifuged again. The pellet was resuspended in 10 ml sterile, cold 10% 
glycerol, centrifuged one final time. The pellet was resuspended in approximatelylml of cold 
10% glycerol. Sixty µI aliquots were frozen in a dry ice-ethanol bath and stored at -70°C until 
used. 
For transformation of E. coli, one tube containing frozen competent E. coli was thawed on 
ice, and 2 µI of the DNA ligation reaction or DNA were mixed with the cells and immediately 
transferred to a cold electroporation cuvette (0.2 mm gap, Bio-Rad Laboratories, Inc.). The cells 
were subjected to electroporation using a BTX Model 600 electroporator, settings of 2.5 kV 
charging voltage, 129 ohms, capacitance of 50 µF, which generates a 5 millisecond pulse length. 
Following electroporation, 1 ml of SOC media was added to the cuvette, which was incubated at 
37°C for 1 hour before plating. Transformants (10 µI, 100 µI and 500 µI volumes) were plated 
on LB plates containing a selective antibiotic and grown overnight in a 37°C incubator. 
Electrocompetent mycoplasmas were always prepared just prior to use as described 
previously (96). Mycoplasma cultures were grown to mid-log phase (slightly orange culture) 
and harvested by centrifugation at 8,500 x g in a J 17 rotor for 10 minutes at room temperature. 
The pellet was resuspended in an equal volume of room temperature electroporation buffer (8 
mM HEPES, 272mM sucrose, pH 7.4, autoclaved) and immediately centrifuged. This pellet was 
resuspended in one half the original volume electroporation buffer and centrifuged. The final 
pellet was resuspended in 1/300 the original volume room temperature electroporation buffer 
and placed on ice. Sixty to one hundred µI aliquots were used within 1 hour. Approximately 10 
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µg of DNA was added to the tube and the cells were immediately transferred to a chilled 
electroporation cuvette. Electroporation conditions used were the same as for E. coli. The 
electroporated cells were immediately resuspended in cold mycoplasma media and incubated at 
room temperature for 10 minutes and then at 37°C for 2-3 hours. One hundred and fifty µl of 
cells were plated onto selective agar (2 µg per ml tetracycline or 40 µg per ml gentamicin). The 
plates were then incubated at 37°C for 5 - 7 days. Transformation frequency was determined by 
dividing the number of resistant colonies by the total colony forming units plated. 
DNA Constructions 
Mini-Tn4001 
The strategy for the construction of mini-Tn400J is shown in Figure 1. For this 
construction, fragments of the transposon Tn4001 were serially inserted into the plasmid 
cloning vector pSK-. Three sets of paired oligonucleotides were used; plus and minus strands 
with the sequences of the inner and outer repeat sequences of 1S256 and PCR primers for the 
transposase gene. 
The outer repeat sequences were cloned first. The two oligomers, TNO+ and TNO-, were 
mixed (50pmole each in a final volume of 50 µ1, Gibco React buffer 2), heated at 70°C for 5 
minutes and slowly cooled to room temperature. The resulting double-stranded fragment was 
precipitated by adding 10 µg of yeast tRNA, 1/3 vol 3M potassium acetate and 2 vol 100% 
ethanol. After centrifugation at 12,000 x g for 20 minutes, the precipitant was resuspended in 
React buffer 2, digested with 20 U of EcoRI and HindIII in a final volume of 50 µl for 1 hour, 
and precipitated as before. The vector was also digested with EcoRI and HindIII (5 µg DNA in 
a 100 µl reaction). The two digested DNA products were ligated in a 20 µl final volume 
containing 500 ng vector, 1 µl of the digested oligomers, 10 U of T4 DNA Ligase, and ligase 
buffer at 16°C for 16 hours. The product was precipitated, digested with EcoRV for 1 hour, 
precipitated again and resuspended in water. One fifth of this product was used to transform 
LE392 by electroporation. Twenty clones were picked and cultured. Plasmid DNAs were 
isolated and digested with EcoRV to check for the presence of inserts (the Eco RV restriction 
site should have been lost during the cloning). One plasmid was sequenced and contained the 
correct outer repeat insert. This plasmid was designated pISM27 and was used for the next 
stage of cloning. 
The same basic protocol was followed for the insertion of the inner repeat sequences. The 
oligonucleotides TNI+ and TNI- were designed with staggered ends so that the annealed 
product did not require restriction digestion. Twenty-five pmoles of the oligomers TNI2+ and 
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Figure 1. Construction of the mini-Tn4001tet. A the multiple cloning site of pSK-; B. the outer 
repeat DNA sequence of Tn4001 inserted into the HindIII and Eco RI restriction sites; C. the 
inner repeat sequence of Tn4001 inserted into the Spel and Sad restriction sites; D. the 
transposase gene inserted into the Kpnl and Sall restriction sites; and E. the Hincll tetM gene-
containing fragment from Tn916 inserted into the Smal restriction site. Inserted sequences are 
underlined or labeled. Only relevant restriction sites are shown. Diagram is not drawn to scale. 
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EcoRV 
A KpnI XhoI SalI HindIII EcoRI PstI SmaI GGGTACCGGGCCCCCCCTCGAGGTCGACGGTATCGATAAGC'ITGATATCGAATTCCTGCAGCCCGG 
BarnHI SpeI NotI SacI 
GGGATCCACTAGTTCTAGAGCGGCCGCCACCGCGGTGGAGCTC 
B KpnI XhoI SalI HindIII GGGTACCGGGCCCCCCCTCGAGGTCGACGGTATCGATAAGC'ITGATAAAGTCCGTATAATTGTGTAA 
EcoRI PstI SmaI BarnHI SpeI NotI SacI 
AAGAATTCCTGCAGCCCGGGGGATCCACTAGTTCTAGAGCGGCCGCCACCGCGGTGGAGCTC 
C KpnI XhoI SalI HindIII GGGTACCGGGCCCCCCCTCGAGGTCGACGGTATCGATAAGC'ITGATAAAGTCCGTATAATTGTGTAAA 
EcoRI PstI SmaI BarnHI SpeI SacI 
t,GAATTCCTGCAGCCCGGGGGATCCACTAGTTTTTACACAGGAGTCTGGACTTGACTGAGCTC 
D KpnI SalI HindIII EcoRI PstI SmaI GGGTACCGTCGACGGTATCGATAAGCTl'GATAAAGTCCGTATAATTGTGTAAAAGAATTCCTGCAGC 
BarnHI SpeI SacI 
CC GGGGGATCCACTAGTTTTTACACAGGAGTCTGGAC'ITGACTGAGCTC 
tetM /4.8 kb J 
7 
--E 
KpnI SalI HindIII EcoRI PstI SmaI 
GGGTACCGTCGACGGTATCGATAAGC'ITGATAAAGTCCGTATAATTGTGTAAAAGAATTCCTGCAGCCCG 
BarnHI SpeI SacI 
GGGGATCCACTAGTTTTTACACAGGAGTCTGGACTTGACTGAGCTC 
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TNI2- were mixed with ligation buffer in a 10 µ1 volume, heated to 67°C for 20 minutes, and 
slowly cooled to room temperature. The vector was prepared in two steps. pISM27 was 
digested with Spel (7.5 µg DNA, 10 µ1 NEB buffer II, 1 µ1 BSA, 10 U Spel in a total volume of 
100 µl, 37°C for 1 hour), precipitated, and then digested with Sad (NEB buffer I, other 
conditions as before). The resulting fragments were purified using a QIAquick PCR 
Purification Kit. The 20 µI ligation reaction containing 50 ng Spel/Sacl-digested plSM27 DNA, 
1 µ1 of the oligomer mix, ligase buffer and 10 U T4 DNA Ligase was incubated at l 6°C 
overnight. Two µl of this reaction mixture was used to transform LE392, and the resulting 
transformants were plated on LB plus ampicillin (100 µg per ml) . Twenty clones were picked 
and processed as described previously. Three were sent for sequencing and all contained the 
correct insert. The selected plasmid with the inner and outer IS256 repeat sequences was 
designated pISM28. 
The Tn4001 transposase gene was obtained by PCR. The oligomers TNPL2 and TNPL3 
were designed to include the transposase promoter and the translational stop sequences. 
Plasmid pISMl 001, which contains Tn4001, was used as the template. The PCR conditions 
were as follows: 100 ng template DNA, 2 µ12mM dNTPs, 1 µ12.5-3 U Pfu enzyme, 5 µl of a 
5pmole per µ1 solution of each primer, 10 µ1 commercial lOX buffer in a final volume of 100 
µl. The reaction conditions were 95°C for 1 min, 5 cycles of 95°C for 45 sec, 45°C for 45 sec 
and 65°C for 2 minutes followed by 35 cycles of 94 °C for 45 sec, 45°C for 45 sec, and 70°C 
for 2 minutes, ending with 70°C for 10 minutes. A portion of the PCR product was resolved on 
a 1 % agarose gel to check for correct size, and then the remaining portion was digested with 
Kpnl (400 ng DNA, 2 µl enzyme, 15 µl lOX React 4, in a final volume of 150 µ1). The fragment 
was precipitated and was then digested with SalI (React 10 buffer, all other conditions the same 
as above). To clone the transposase gene, Kpnl and SalI-digested PISM28 was resolved on a 
0.6% Nu-Sieve preparative gel, and the band containing the vector was isolated using a QIAEX 
II Agarose Gel Extraction Kit. Forty four ng of the double digested pISM28 DNA was ligated 
overnight at 14 °C with 2 µ1 of the digested transposase product in a 10 µ1 reaction volume 
containing 0.5 µ1 T4 DNA Ligase. Two µ1 of this ligation mixture was electroporated into 
LE392 and plated as usual. Twenty colonies were picked, processed, and restriction digested as 
before. Three were selected for sequencing. To sequence across the entire transposase gene, it 
was necessary to design an internal oligomer, IS256. One clone containing the complete, correct 
transposase sequence was designated pISM29, also known as mini-Tn4001 . 
The tetM marker from Tn916 was then inserted between the inner and outer repeat 
sequences in the following way. The tetM gene was obtained from plasmid pISM1002 on a 
Hincll fragment (89). Plasmid pISM1002 DNA was digested with Hincll for 30 minutes at 
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37°C under the following conditions: 15 µg of plasmid DNA, 50 U HincIT, 10 µI of lOX React 
4 buffer in a final volume of 100 µI. The product was purified on a 1 % agarose preparative gel 
and isolated as described above. Plasmid pISM29 was digested with Smal (15 µg DNA, 40 U 
of Smal, 15 µI of lOX React 4 buffer in a final volume of 150 µl) at 37°C for 30 minutes, 
precipitated and resuspended in water. The final ligation mixture containing 180 ng pISM29, 
440 ng of the tetM containing fragment DNA, and 5 U of T4 DNA Ligase in a 25 µI final 
volume was incubated at 14 °C overnight, precipitated, and resuspended in water. Two µI of this 
ligation reaction were used to transform LE392. Ten µI of the cells were spread on media 
containing 100 µg per ml ampicillin and 12.5 µg per ml tetracycline and incubated overnight. 
No colonies were observed, so 50 µI of the same transformation mixture were plated on plates 
containing only 100 µg per ml ampicillin and grown overnight. The resulting 60 colonies were 
picked and streaked on Amp/f et plates, and one colony grew. Restriction digests confirmed that 
this clone did carry the tetM gene. It was given the designation pISM31, also known as mini-
Tn4001tet. 
Green Fluorescent Protein 
The goal of these studies was to alter the codon usage pattern of a GFP gene from a Gram 
negative-optimized sequence to a mycoplasma-specific one. To accomplish this, a GFP DNA 
sequence was designed that utilized mycoplasma codon usage preferences to code for a GFP 
protein product. The amino acid sequence of GFPuv was used as the starting sequence for the 
new gene (Clontech). Two amino acid substitutions were made (S65G and S72A) which are 
found in the sequence of the highly fluorescent GFP mutant, GFPmut3 (24). Codon usage 
tables were obtained for M. gallisepticum (1) and several other mycoplasma species. This 
codon usage data was used to derive a DNA sequence employing the most frequently used 
codons for each amino acid in the modified amino acid sequence described above. There is only 
one tryptophan in the gene (amino acid 57), and the mycoplasma-preferred codon TGA, a stop 
codon in the universal genetic code was used. For clarity, the designation "GFPmyco" will 
refer only to the GFP sequence optimized for mycoplasmas described above. 
The GFPmyco sequence was divided into two parts referred to as GFP-1 (5' end of the 
gene) and GFP-2 (3' end of the gene). Each fragment contained an internal Eco RV (blunt end) 
restriction site, which would be used to join the two gene halves. Overlapping 50 mer 
oligonucleotides were designed to span the fragment, and two PCR primers were designed to 
amplify portions of the fragment (Table 3). 
First, the positive and negative strand oligomers were divided into separate tubes and treated 
with DNA T4 kinase.(2 µI of each 12.5 pmol oligomer, ligase buffer, 10 U T4 DNA kinase 
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37°C for 30 minutes). Then 15 µl of each reaction was mixed with that of the opposite strand, 
heated to 95°C, and slowly cooled to room temperature in a temperature block to allow 
annealing. Ten µl of each mixture, now largely in the form of nicked, double-stranded DNA, 
was ligated in a reaction containinglO µl annealed solution, ligase buffer and 5 U T4 Ligase 
atl6°C overnight. The double stranded segment produced was amplified by PCR using the 
following conditions. The mixture containedlO0 ng template, 2 µM dNTPs, 25 pmol each 
primer, 10 µl commercial lOX PCR buffer plus 0.5mm MgC12 and 4 U Pfu enzyme in a 100 µl 
final volume. The reaction conditions were 35 cycles at 94°C for 45 sec, 55°C for 45 sec, 72°C 
for 1 min (GFP-1) or 1.15 min (GFP-2) followed by 72°C for 10 min. The PCR products were 
resolved on a 1 % agarose gel and compared with a 1 kb plus standard to confirm their sizes. 
The GFP-1 fragment was about 300 bp and contained a 5' BamHl site and a 3' EcoRV site. The 
500 bp GFP-2 fragment contained a 5' EcoRV site and a 3' EcoRI site. Each purified fragment 
was cloned by double digesting and ligating it into the appropriately digested pZerO2™. 
Following transformation into LE392, the transformation mix was plated on LB plates 
containing 25 µg per ml kanamycin. DNA was isolated using E.N.Z.A Plasmid Miniprep Kits, 
and those preparations carrying plasmid inserts of the correct size were sent for sequencing. 
Two clones with the correct sequences, designated pISM33 and pISM34 were used for the next 
stage of assembly. 
Plasmids pISM33 and pISM34 were digested with EcoRV (10 µg DNA, 15 µl lOX buffer, 
50 U EcoRV in a final volume of 150 µlat 37°C for 1 hour), precipitated and then digested with 
EcoRI (GFP-2) or BamHI (GFP-1). The GFP-1 and GFP-2 fragments were isolated from 2% 
soft agar gels using QIAX Agarose Gel Extraction Protocol Kits. The vector pSK was double-
digested with EcoRI and BamHl. The two inserts and the digested vector were ligated together 
(7.2 ng GFP-1, 16.8 ng GFP-2, 10 ng vector, 2 U T4 Ligase at 16°C for 1 hour), precipitated 
and digested with EcoRI (10 U EcoRl in a 50 µl reaction volume at 37°C for 1 hour). The 
proper clone would be refractory to EcoRI digestion. Two µl of this product were used to 
transform LE392 with selection on ampicillin agar. Colonies were picked, cultured and 
restriction digested as before. One possible clone was sent for sequencing. It contained the 
complete, correct GFP for mycoplasma gene sequence (GFPmyco) and was designated 
pISM32. 
In order to maximize gene expression in mycoplasmas, it was decided to attach the P2 
promoter, a strong mycoplasma promoter that is also functional in E. coli (76). To accomplish 
this, PCR was used to add a BamHI restriction site to the 5' end of the promoter ( 100 ng 
template pISM2050.2, 2 µM dNTPs, 25 pmol each primer, 10 µl lOX PCR buffer plus 0.5 mM 
MgC12, and 4 U Pfu enzyme in a 100 µl volume) using conditions of 35 cycles of 94 °C for 45 
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sec, 60-65°C for 45 sec, 72°C for 2 min, followed by 72°C for 10 min. The primers AcP2R and 
AcP2F were used. 
The final P2:GFPmyco construct was assembled in two stages, P2:GFPmyco ligation and 
amplification was followed by insertion of the P2:GFPmyco fragment into the Tn400Jmod of 
plasmid pISM2062. P2 and GFP fragments were blunt end ligated (60 ng each DNA, ligase 
buffer, 5 U T4 DNA Ligase in final volume of 20 µlat 16°C overnight). This ligation mixture 
showed no visible product by gel analysis, but was used as the template for a PCR reaction 
using primers GFPMyF and CM33R.Bam (see conditions above). The resulting PCR product 
was digested with BamHl and ligated into BamHI-digested, dephosphorylated pISM2062. 
Dephosphorylation was accomplished with calf intestinal phosphatase (1 µg DNA, 2 U CIP in 
a final volume of 30 µl for 60 minutes at 37°C) followed by proteinase K digestion (10 µl 
10%SDS, 25 µl lM Tris, pH 7.4, 11 U Proteinase K, 0.5 µl 0.5 M EDTA in a final volume of 
100 µl for 1 hr at 65°C), and phenol:chloroform extracted. A final ligation joined the BamHI 
vector and insert fragments (100 ng BamHI-digested pISM2062 DNA, 120 ng BamHI-
digested P2:GFPmyco fragment in a 20 µl reaction volume at l4°C overnight). The product was 
heat inactivated at 70°C for 15 minutes, precipitated, resuspended in 3 µl of water, and 
transformed into LE392. Transformants were plated on LB plus 100 µg per ml ampicillin. 
Plasmid DNAs from twenty of the resulting colonies were analyzed by restriction digestion. 
One clone containing the complete P2:GFPmyco sequence was designated pISM30. The 
construct was confirmed by DNA sequence. 
Functional Studies 
Mini-Tn4001tet 
The functionality of mini-Tn400Jtet was tested by transformation of pISM31 into M. 
gallisepticum. Plasmid DNA was prepared using the Qiagen midi-kit, and electrocompetent M. 
gallisepticum were prepared as described above. Ten µg of plasmid DNA were mixed with 100 
µl of competent cells and electroporated as previously described. Following incubation at 37°C, 
the cells were centrifuged at 12,000 x g for 2 minutes, resuspended to 150 µl in phosphate 
buffered saline, and 100 µl of the cell suspension was plated on PPLO agar containing 2 µg per 
ml tetracycline. Colony forming units were determined by plating serial dilutions in PBS on 
non-selective PPLO agar. Plates were incubated at 37°C for 10 days prior to counting. 
Putative transformants were picked randomly, grown in 1 ml of non-selective PPLO media 
overnight and then diluted to 10 ml with selective media containing 2 µg per ml tetracycline. 
Aliquots were frozen for future analysis, and the remaining cells, representing approximately 8 
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rnls of fully grown cells, were centrifuged to pellet the cells. Chromosomal DNA was prepared 
from these cells using the QIAarnp DNA mini kit (Qiagen). The DNA was analyzed for the 
presence of the transposon using tetM-specific primers in a PCR reaction. To control for 
plasmid insertion, another PCR reaction was run with bla primers, which should only produce a 
product when the plasmid arnpicillin resistance gene is present. 
GFP 
Prior to determining if GFPmyco could function in mycoplasmas, its fluorescent signal was 
examined in E. coli. This seemingly simple experiment was compounded by the presence of a 
UGA codon in the GFPmyco reading frame. To suppress the UGA codon, pISM32 was 
transformed into the opal suppressor strain E. coli ISM614, and the resulting transformants 
were examined for fluorescence. 
To transform GFPmyco into M. gallisepticum R, electrocompetent cells were prepared for 
transformation as described above. Ten µg of pISM32 DNA was used to transform M. 
gallisepticum. Half were plated on phenol red containing PPLO selective media and half were 
plated on phenol red-free PPLO selective media. The presence of phenol red complicates 
analysis since it fluoresces at the same wavelength as GFP. All plates were incubated at 37°C 
until colonies appeared (7-10 days). After 10 days, the colonies on the phenol red-free plates 
were viewed with an UV light box. Colonies were picked from the plates using sterile pasteur 
pipettes and grown in 1 ml of non-selective, phenol red-containing media until the media turned 
slightly orange (usually 1-2 days). Each culture was then split 1/10 into two tubes of selective 
media containing 40 µg per ml gentarnicin. One of the tubes contained phenol red, and the 
second did not. Mid log phase phenol red-containing cultures (slightly orange) were pelleted 
and frozen for future DNA studies. The equivalent phenol red-free cultures were examined for 
fluorescence. 
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RESULTS AND DISCUSSION 
Mini-Tn4001tet 
Mini transposons have been used for many kinds of genetic studies including mutant 
construction, gene expression studies, protein function analyses and cellular tagging. Their 
compact size and ease of manipulation make them excellent genetic tools (9). The mini 
transposon structure also eliminates some unfortunate genetic behaviors characteristic of native 
transposons. In particular, the movement of the transposase to outside the inverted repeats, and 
its subsequent loss from the cell, does away with multiple transposition events and spontaneous 
deletions (36). 
Mini-transposons offer other advantages that make them ideal genetic tools. They are 
designed so that they can easily be altered to suit a particular experimental system. For example, 
genes are easily inserted into the multiple cloning sites located between the inverted repeats. 
Modifications may include changes in antibiotic resistant markers (36) or the exchange of an 
antibiotic resistance for another selectable marker (109). Reporter genes are also often used 
with mini-transposons. 
While mini transposons have been developed for analysis of both Gram negative and Gram 
positive bacteria, no such tools have been available for use with mycoplasmas. In fact, only two 
transposons are known to function in mycoplasmas, Tn916 and Tn4001 (42). When deciding 
on the starting element for such a construction, the complexity and size of the conjugative 
transposon Tn916 was thought to be a difficult barrier to overcome. Tn4001, however, is 
structurally similar to Tn5 making it an ideal candidate for these studies. In addition, this 
laboratory has a history of successful genetic manipulation of Tn4001 (75). Thus, the decision 
was made to develop a mini-Tn400J derivative for use in mycoplasmas. 
The structure of the mini-Tn4001 was based on the structure of mini Tn5 (36). Mini Tn5 
contains the inner and outer repeat sequences of the insertion sequence IS5 flanking a selective 
marker. The IS256 ofTn4001 is the source of the mini-Tn400J outer and inner repeats 
(Figures 1 and 2). The transposase is supplied in cis outside the repeat sequences. Since 
plasmids with E. coli compatible origins of replication act as suicide vectors in mycoplasmas, 
the transposase is lost during cell replication even after insertion of the mini-transposon into the 
chromosome. 
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GGGTACCGTGTAAAAGTAAAAAGGCCATATAACAGTCCTTTTACGGTACAATGTTTTTAACGACAAAAAC 70 
Transposase> M T Q V H N T L K S E E I Q S I I 
ATACCCAGGAGGACTTTTACATGACCCAAGTACATTTTACACTGAAAAGCGAAGAGATTCAAAGCATTAT 140 
E Y S V K D D V S K N I L T T V N N Q L M E N 
TGAATATTCTGTAAAGGATGACGTTTCTAAAAATATTTTAACAACGGTATTTAATCAACTAATGGAAAAT 210 
Q R T E Y I Q A K E Y E R T E N R Q S Q R N G 
CAACGAACAGAATATATTCAAGCAAAAGAATATGAACGAACAGAAAACCGACAAAGTCAACGAAATGGCT 280 
Y Y E R S N T T R V G T L E L K V P R T R D G H 
ATTATGAGCGCAGCTTTACGACACGTGTAGGCACGCTAGAATTAAAAGTACCCAGAACACGTGATGGCCA 360 
N S P T V N E R Y Q R N E K A L M A S M L E M 
TTTTTCACCCACAGTGTTTGAACGTTATCAACGAAACGAAAAAGCCCTCATGGCTTCAATGTTGGAAATG 420 
Y V S G V S T R K V S K I V E E L C G K S V S 
TATGTATCAGGCGTTTCAACTCGTAAAGTATCAAAAATTGTGGAAGAACTTTGTGGTAAATCCGTCTCTA 490 
K S F V S S L T E Q L E P M V N E W Q N R L L S 
AGTCCTTCGTTTCTAGCTTAACAGAACAGCTAGAACCTATGGTTAACGAGTGGCAGAATCGTTTATTATC 560 
E K N Y P Y L M T D V L Y I K V R E E N R V L 
AGAAAAAAATTATCCTTACTTAATGACCGATGTACTCTATATAAAAGTACGAGAAGAAAATCGAGTACTC 630 
S K S C H I A I G I T K D G D R E I I G F M I 
TCAAAAAGCTGTCATATAGCGATTGGAATAACCAAAGATGGCGACCGTGAAATTATCGGCTTCATGATTC 700 
Q S G E S E E T W T T N N E Y L K E R G L Q G T 
AAAGTGGCGAAAGCGAAGAGACCTGGACAACATTTTTTGAATACCTAAAAGAACGCGGTTTACAAGGTAC 770 
E L V I S D A H K G L V S A I R K S F T N V S 
GGAACTCGTTATTTCTGATGCGCACAAAGGATTAGTCTCTGCCATTAGAAAATCCTTCACCAACGTAAGT 840 
W Q R C Q V H F L R N I N T T I P K K N S K S 
TGGCAAAGATGCCAAGTTCACTTCCTAAGAAATATCTTTACCACCATTCCTAAAAAAAATTCAAAATCTT 910 
F R E A V K G I N K F T D I N L A R E A K N R L 
TCAGAGAAGCTGTTAAAGGAATTTTTAAGTTCACAGATATTAACTTAGCGCGTGAGGCTAAAAATCGATT 980 
I H D Y I D Q P K Y S K A C A S L D D G F E D 
GATTCATGATTATATCGATCAACCAAAATATTCAAAAGCTTGCGCATCATTGGATGATGGATTCGAAGAC 1050 
A N Q Y T V Q G N S H N R L K S T N L I E R L 
GCCTTTCAATATACCGTACAAGGAAATTCCCACAATCGACTAAAGAGTACCAATCTAATTGAACGACTGA 1120 
N Q E V R R R E K I I R I F P N Q T S A N R L I 
ATCAAGAAGTACGCAGAAGAGAAAAGATTATTCGCATCTTCCCCAATCAAACATCAGCCAATCGCTTAAT 1190 
G A V L M D L H D E W I Y S S R K Y I N N D K 
TGGAGCCGTTCTTATGGACCTACATGATGAATGGATTTATTCTTCAAGAAAATACATCAATTTTGATAAG 1260 
* 0 
TAGAAATGGGTCGACGGTATCGATAAGCTTGATAAAGTCCGTATAATTGTGTAAAAGAATTCCTGCAGCC 1330 
CGTCAACATACTTCTTGCGATTATACAGGTGGAATCGGGCGGTACTGCGGAAGATGTTATGCAGTCCTCG 1400 
Figure 2. DNA sequence of mini-Tn4001tet. 0, 5' end of outer repeat (underlined); I, 5' end of 
inner repeat (underlined). Amino acid sequences of transposase and TetM proteins are listed 
under the corresponding DNA sequence. The sequence of the HincI1. fragment ( containing 
tetM) was taken from Flannagan ( 47). 
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GAATCCCTCGGTCTTCCACCTAATTCATTGAGTACAGAAGAATCCATTAAGCAAGGTGTGAAGTATTTCA 1470 
GTGAATTATTAGCCAGTAGCGAAAGGCTCAGTGTAGATTTAGAATCGGTTATCCAGTCCTACAATTATGG 1540 
TGGTGGTTTCTTAGGGTATGTGGCTAATCGTGGAAATAAATATACCTTTGAACTGGCTCAAAGTTTCTCA 1610 
AAAGAGTATTCAGGTGGCGAAAAAGTGTCTTACCCCAATCCCATAGCCATACCTATCAATGGGGGCTGGC 1680 
GATACAACTATGGCAATATGTTTTATGTGCAACTGGTAACGCAGTATCTTGTCACAACAGAGTTTGATGA 1750 
TGATACGGTACAAGCCATCATGGACGAAGCACTGAAATATGAGGGCTGGCGATACGTTTACGGTGGAGCT 1820 
TCCCCGACTACTTCTTTTGATTGTAGCGGACTGACACAATGGACGTATGGAAAAGCTGGAATTAACTTAC 1890 
CACGAACCGCACAACAGCAATATGATGTGACCCAGCATATCCCACTATCGGAAGCACAAGCTGGCGATTT 1960 
GGTTTTCTTTCATTCTACCTATAACGCTGGCTCTTATATTACTCATGTTGGGATATACCTTGGCAATAAC 2030 
CGTATGTTTCATGCAGGCGACCCAATCGGTTATGCCGACTTAACAAGCCCCTACTGGCAACAGCATTTAG 2100 
TGGGAGCAGGACGAATCAAACAATGAGAAAGGAAGATTTAATGATGAAATTTAGAAAAAATCAGAATAAA 2170 
GAAAAACAGATACCAAAGGAAAAGAAACCTCGTGTCTATAAGGTCAATCCTCATAAAAAGGTTGTGATTG 2240 
CCTTGTGGGTACTTTTAGGGCTTAGTTTCAGCTTTGCGATATTCAAGCACTTTACAGCTATAGATACTCA 2310 
TACTATTCACGAAACAACTATCATAGAAAAGGAATACGTTGATACTCATCATGTAGAAAATTTTGTAGAG 2380 
AACTTTGCGAAAGTCTACTATTCATGGGAGCAATCCGATAAGTCCATTGATAATCGAATGGAAAGTCTAA 2450 
AAGGCTATCTGACAGATGAACTTCAAGCTCTCAATGTTGATACAGTACGCAAAGATATTCCTGTATCGTC 2520 
TTCTGTAAGAGGATTTCAGATATGGACGGTAGAGCCAACTGGCGACAATGAGTTTAATGTAACCTACAGT 2590 
GTAGACCAGCTCATTACAGAGGGAGAAAATACAAAGACCGTCCACTCTGCTTATATAGTGAGTGTCTATG 2660 
TAGATGGTTCTGGAAATATGGTACTGGTTAAGAATCCGACCATTACCAACATACCTAAGAAATCAAGTTA 2730 
TAAACCAAAAGCCATTGAAAGTGAGGGGACGGTTGATTCCATTACAACCAATGAAATCAATGAGTTTTTA 2800 
ACGACGTTCTTCAAGCTCTATCCTACAGCGACAGCCAGTGAACTTTCCTACTATGTGAATGACGGGATAT 2870 
TAAAACCAATCGGAAAAGAGTACATCTTTCAAGAACTGGTAAATCCTATTCACAATCGTAAGGATAATCA 2940 
AGTCACGGTATCGCTGACAGTGGAGTATATCGACCAGCAGACCAAAGCAACGCAGGTATCTCAATTTGAT 3010 
TTGGTACTTGAAAAGAACGGGAGTAATTGGAAGATTATAGAATAACAAATATTGGTACATTATTACAGCT 3080 
ATTTTGTAATCACGTACTCTCTTTGATAAAAAATTGGAGATTCCTTTACAAATATGCTCTTACGTGCTAT 3150 
TATTTAAGTATCTATTTAAAAGGAGTTAATAAATATGCGGCAAGGTATTATTAAATAAACTGTCAATTTG 3220 
ATAGCGGGAACAAATAATTGGATGTCCTTTTTTAGGAGGGCTTAGTTTTTTGTACCCAGTTTAAGAATAC 3290 
CTTTATCATGTGATTCTAAAGTATCCGGAGAATATCTGTATGCTTTGTATGCCTATGGTTATGCATAAAA 3360 
tetM> 
ATCCCAGTGATAAGAGTATTTATCACTGGGATTTTTATGCCCTTTTGGGCTTTTGAATGGAGGAAAATCA 3430 
M K I I N I G V L A H V D A G K T T L T E S L 
CATGAAAATTATTAATATTGGAGTTTTAGCTCATGTTGATGCAGGAAAAACTACCTTAACAGAAAGCTTA 3500 
L Y N S G A I T E L G S V D K G T T R T D N T 
TTATATAACAGTGGAGCGATTACAGAATTAGGAAGCGTGGACAAAGGTACAACGAGGACGGATAATACGC 3570 
L L E R Q R G I T I Q T G I T S N Q W E N T K V 
TTTTAGAACGTCAGAGAGGAATTACAATTCAGACAGGAATAACCTCTTTTCAGTGGGAAAATACGAAGGT 3640 
N I I D T P G H M D F L A E V Y R S L S V L D 
GAACATCATAGACACGCCAGGACATATGGATTTCTTAGCAGAAGTATATCGTTCATTATCAGTTTTAGAT 3710 
G A I L L I S A K D G V Q A Q T R I L N H A L 
GGGGCAATTCTACTGATTTCTGCAAAAGATGGCGTACAAGCACAAACTCGTATATTATTTCATGCACTTA 3780 
Figure 2. (Continued) 
37 
R K M G I P T I N N I N K I D Q N G I D L S T V 
GGAAAATGGGGATTCCCACAATCTTTTTTATCAATAAGATTGACCAAAATGGAATTGATTTATCAACGGT 3850 
Y Q D I K E K L S A E I V I K Q K V E L Y P N 
TTATCAGGATATTAAAGAGAAACTTTCTGCCGAAATTGTAATCAAACAGAAGGTAGAACTGTATCCTAAT 3920 
V C V T N N T E S E Q W D T V I E G N D D L L 
GTGTGTGTGACGAACTTTACCGAATCTGAACAATGGGATACGGTAATAGAGGGAAACGATGACCTTTTAG 3990 
E K Y M S G K S L E A L E L E Q E E S I R N Q N 
AGAAATATATGTCCGGTAAATCATTAGAAGCATTGGAACTCGAACAAGAGGAAAGCATAAGATTTCAGAA 4060 
C S L F P L Y H G S A K S N I G I D N L I E V 
TTGTTCTCTGTTCCCTCTTTATCATGGAAGTGCAAAAAGTAATATAGGGATTGATAACCTTATAGAAGTT 4130 
I T N K N Y S S T H R G P S E L C G N V F K I 
ATTACTAATAAATTTTATTCATCAACACATCGAGGTCCGTCTGAACTTTGCGGAAATGTTTTCAAAATTG 4200 
E Y T K K R Q R L A Y I R L Y S G V L H L R D S 
AATATACAAAAAAAAGACAACGTCTTGCATATATACGCCTTTATAGTGGAGTACTACATTTACGAGATTC 4270 
V R V S E K E K I K V T E M Y T S I N G E L C 
GGTTAGAGTATCAGAAAAAGAAAAAATAAAAGTTACAGAAATGTATACTTCAATAAATGGTGAATTATGT 4340 
K I D R A Y S G E I V I L Q N E N L K L N S V 
AAGATTGATAGAGCTTATTCTGGAGAAATTGTTATTTTGCAAAATGAGTTTTTGAAGTTAAATAGTGTTC 4410 
L G D T K L L P Q R K K I E N P H P L L Q T T V 
TTGGAGATACAAAACTATTGCCACAGAGAAAAAAGATTGAAAATCCGCACCCTCTACTACAAACAACTGT 4480 
E P S K P E Q R E M L L D A L L E I S D S D P 
TGAACCGAGTAAACCTGAACAGAGAGAAATGTTGCTTGATGCCCTTTTGGAAATCTCAGATAGTGATCCG 4550 
L L R Y Y V D S T T H E I I L S F L G K V Q M 
CTTCTACGATATTACGTGGATTCTACGACACATGAAATTATACTTTCTTTCTTAGGGAAAGTACAAATGG 4620 
E V I S A L L Q E K Y H V E I E L K E P T V I Y 
AAGTGATTAGTGCACTGTTGCAAGAAAAGTATCATGTGGAGATAGAACTAAAAGAGCCTACAGTCATTTA 4690 
M E R P L K N A E Y T I H I E V P P N P F W A 
TATGGAGAGACCGTTAAAAAATGCAGAATATACCATTCACATCGAAGTGCCGCCAAATCCTTTCTGGGCT 4760 
S I G L S V S P L P L G S G M Q Y E S S V S L 
TCCATTGGTTTATCTGTATCACCGCTTCCGTTGGGAAGTGGAATGCAGTATGAGAGCTCGGTTTCTCTTG 4830 
G Y L N Q S N Q N A V M E G I R Y G C E Q G L Y 
GATACTTAAATCAATCATTTCAAAATGCAGTTATGGAAGGGATACGCTATGGTTGTGAACAAGGATTGTA 4900 
G W N V T D C K I C N K Y G L Y Y S P V S T P 
TGGTTGGAATGTGACGGACTGTAAAATCTGTTTTAAGTATGGCTTATACTATAGCCCTGTTAGTACCCCA 4970 
A D N R M L A P I V L E Q V L K K A G T E L L 
GCAGATTTTCGGATGCTTGCTCCTATTGTATTGGAACAAGTCTTAAAAAAAGCTGGAACAGAATTGTTAG 5040 
E P Y L S N K I Y A P Q E Y L S R A Y N D A P K 
AGCCATATCTTAGTTTTAAAATTTATGCGCCACAGGAATATCTTTCACGAGCATACAACGATGCTCCTAA 5110 
Y C A N I V D T Q L K N N E V I L S G E I P A 
ATATTGTGCGAACATCGTAGACACTCAATTGAAAAATAATGAGGTCATTCTTAGTGGAGAAATCCCTGCT 5180 
R C I Q E Y R S D L T F N T N G R S V C L T E 
CGGTGTATTCAAGAATATCGTAGTGATTTAACTTTCTTTACAAATGGACGTAGTGTTTGTTTAACAGAGT 5250 
Figure 2. (Continued) 
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L K G Y H V T T G E P V C Q P R R P N S R I D K 
TAAAAGGGTACCATGTTACTACCGGTGAACCTGTTTGCCAGCCCCGTCGTCCAAATAGTCGGATAGATAA 5320 
V R Y M F N K I T * 
AGTACGATATATGTTCAATAAAATAACTTAGTGTATTTTATGTTGTTATATAAATATGGTTTCTTGTTAA 5390 
ATAAGATGAAATATTTTTTAATAAAGATTTGAATTAAAGTGTAAAGGAGGAGATAGTTATTATAAACTAC 5460 
AAGTGGATATTGTGTCCTGTATGTGGAAATAAAACACGATTAAAGATAAGGGAAGATACTGAATTAAAAA 5530 
AATTCCCCCTCTATTGTCCGAAATGCAGACAAGAAAATTTAATTGAAATAAAGCAGTTCAAAGTAACTGT 5600 
GATTACAGAGCCAGACGCAAAGACGCAGAGCCGATAAAATGAGATTAATACAATCTCATTTTATCGGCTC 5670 
TTTCCGTTATGTATGGATTCTTTTAATTAGTCTTCGATGTTTCTTGCTTCGTTGATACCGCTGGCTAAAG 5740 
ATTCCATTAAGGATAGTTCTTTGTCTGTAAAGCTATCCATGTATTTCTCTATCTGTAATCGTCGGGTGCT 5810 
TTTTACCAAGTTATTAGCAGGTAAGAAAAATTCATCAACGGAAACATGAAGTAACGATACAAGGTCATAA 5880 
AGAACTTGTATGCTGGGGTGTTGCCCTTTATTTTCAATATTAGTTAAGTACCGTGGGTCAATTTCAATCA 5950 
ATGCTCCCACTTGTTCACGAGTTAAACCTCGTTGCAATCGAGCTTCTTTAATGGCTAAACCAAAGGCTCT 6020 
AAAATCATATTTATCTTCTTTTTTACGCATAGTAGACCACCTCTATACATTTTATTGTTCCTACTGAATT 6090 
AAAAACAGGTATAGAAAAACGTGTTATATGGTTTATAGGTTTATATTTAATAAAAAGCACTACTAAACGC 6160 
CAATAAAAAAAACCGTTATATGGTAGTGCTATTTACGCTGTTAAAATATTGTATATTACTTCCAAATGGC 6230 
I 
GGTTTGTTGGAGGTCAACGGGGGATCCACTAGTTTTTACACAGGAGTCTGGACTTGACTGAGCTC 6295 
Figure 2. (Continued) 
To test the functionality of min-Tn400ltet, it was transformed into M. gallisepticum R by 
electroporation. The results of those experiments are shown in Table 4. The transformation 
frequency of the mini-transposon ranged from 1.8 x 10-7 to 2.4 10·1, which is in the range of the 
wild type Tn4001 (1 x 10-6 - 1 x 10·1)(17). For unknown reasons, the plasmid containing mini-
Tn400ltet replicated at a very low copy number, and obtaining sufficient concentrations of 
plasmid DNA for the transformation experiments was problematic. This may explain the 
somewhat lower transformation frequency observed. 
Table 4. Results of transformation experiments with mini-Tn4001tet in M. gallisepticum. 
Exp.# CFUs per ml # Transformants per vol Tf* 
1 5.3 X 108 25 per 20 µl 2.4 X 10-7 
2 6.2 X 109 35 per 30 µl 1.8 X 10·7 
3 3.9 X 109 71 per 100 µl 1.8 X 10·7 
Tf = transformation frequency as determined by dividing the number of resistant colonies by 
the total colony forming units plated 
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PCR were used to confirm the insertion of mini-Tn400ltet into the M. gallisepticum. 
Transformed colonies were picked as described earlier and chromosomal DNA was isolated. 
The PCR primers tetM.1 and tetM.2 were used to screen for the tetM marker in the mini-
transposon, and the primers THl 11 and THl 12 were used to screen for the ampicillin 
resistance marker. The presence of the latter would indicate that the plasmid had integrated into 
the chromosome by homologous recombination. The results of the PCR experiments are shown 
in Figure 3. All of the transformants demonstrated the presence of the tetM marker indicating 
insertion of mini-Tn400ltet into the chromosome. Two of the 9 transformants tested also had 
bla sequences (the ampicillin resistance marker) indicating that in these transformants, the 
plasmid may also be integrated into the chromosome. Further experiments will be needed to 
determine if integration of the plasmid occurs at a high frequency and whether this will be a 
problem with plasmid pISM3 l. 
1 ~ J 4 5 ti 7 8 !:I 1U 11 
Figure 3. PCR analysis of M. gallisepticum mini-Tn400ltet transformants. Upper. tetM-
specific primers. Lower. bla-specific primers. Lane 1, lkb+ base pair ladder; lanes 2-10, M. 
gallisepticum transformants; lane 11, control (pISM31). 
Although mini-transposons have been constructed for use in many bacterial systems, few 
have been used in Gram positive bacteria, and they have not been available for mycoplasma 
researchers. Our prototype, mini-Tn400ltet is functional in mycoplasmas and should be useful 
for a variety of genetic and protein expression studies. The replacement of the tetracycline gene 
by other markers should be technically trivial and allow for the construction of a family of mini-
Tn4001 derivatives as a needed for specific experimental systems. Several resistance markers 
could be substituted including gentarnicin, erythromycin, and chloramphenicol acetyl 
transferase. In addition at least two reporter genes can be used, ~-galactosidase (lacZ), PhoA 
(95), and tetM (95). Eventually, GFP and many other reporter genes will be developed for use in 
mycoplasmas. 
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GFPmyco 
Green fluorescent protein variants, while relatively new, have already been shown to be 
exceptionally flexible markers, especially for in vivo labeling. A number of groups have 
obtained interesting results expressing two variants in the same cell. In some cases a single 
mini-transposon system has transported the genes for two different GFP markers (72, 105, 133, 
136). However, GFP has not been expressed in mycoplasma systems. In the one published 
account of the use of GFP for mycoplasmal studies, Dhandayuthapani et al. used it as a marker 
for retrieving potential promoter sequences from a mycoplasma cDNA library (38) but the GFP 
was visualized in E. coli,. They presented no data on GFP expression in mycoplasma. 
GFPuv (Clontech), is a commonly used GFP variant with an efficient promoter and 
sequence optimized for translation in E. coli. An overnight E. coli culture containing this 
plasmid has a glowing yellow green color under fluorescent or daylight conditions. Initial 
attempts to express this protein in M. gallisepticum were unsatisfactory (95). There was some 
protein production, but the fluorescence levels were so low that they were only faintly visible 
with a confocal microscope. Since the promoter system, plasmid carriers, etc. used in these 
experiments were known to function in M. gallisepticum, it was hypothesized that the codon 
usage of the GFPuv gene was negatively impacting protein translation rates and preventing the 
production of observable quantities of translated product. 
To overcome this problem, a new GFP gene sequence was designed utilizing codons 
favored by mycoplasma translation systems. The design of the coding sequence is shown in 
Figure 4. GFPuv, which has a prokaryote-optimized DNA sequence was used as the starting 
sequence. This sequence differs from wild type in three amino acids. These substitutions which 
increase the fluorescence signal were also incorporated into the GFPmyco sequence. Two more 
mutations were introduced into the sequence at amino acids 65 (S65G) and 72 (S72A). These 
mutations have been shown to enhance folding and fluorescence in other GFP variants. All are 
shown, along with the final amino acid sequence, in Figure 4. The final DNA sequence is 
shown in Figure 5. The gene assembly strategy is summarized in Figure 6. The GFPmyco gene 
was constructed using an overlap technique in which the genome was divided into sets of long, 
overlapping, bi-directional oligonucleotides as shown in Figure 7. 
The construction of the mycoplasma-optimized sequences was complicated by the AT 
richness of the sequences. This caused difficulties in PCR primer design. Theoretically the 
long runs of adenines and thymidines could also cause misalignments in the annealing stage 
preventing proper assembly. In fact, several clones that were sequenced did appear to be the 
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products of aberrant assembly. For assembly of the final GFP gene, only clones with the 
correct sequence were used. 
The second phase of the construction, the addition of the P2 promoter to the GFPmyco 
gene, required a final PCR step to obtain sufficient material for cloning. It was not possible to 
identify the correct sized band in the ligation mixtures. In fact, the only visible bands were the 
unligated products. This could have resulted from damaged fragments or may have simply been 
due to the fact that it was a blunt end ligation. In any event, a final PCR step was included to 
obtain a sufficient quantity of the correct product for the final cloning into pISM2062. 
PISM262 carries a Tn4001 derivative, Tn400Jmod, which has unique Smal and BamHI sites 
just inside of the inverted repeat (75). BamHI sites had previously been added to each end of 
the P2:GFP fragment during PCR manipulations. As always, Pfa_polymerase was used in this 
final PCR reaction to reduce the error rate. Initial attempts to use Taq polymerase in the 
construction process had resulted in multiple sequence errors, and it was replaced with Pfa. 
10 20 30 40 
GFPwt MSK GEE LFT GVV PIL VEL DGD VNG HKF svs GEG EGO ATY GKL TLK FIC 
GFPuv ... > 
GFPmyco ... . . . ... > 
50 60 70 80 90 
GFPwt TTG KLP VPW PTL VTT FSY GVQ CFS RYP OHM KRH OFF KSA MPE GYV QER 
GFPuv ... > 
GFPmyco .G. . .A ... > 
100 110 120 130 140 
GFPwt TIF FKD DGN YKT RAE VKF EGO TLV NRI ELK GID FKE DGN ILG HKL EYN 
GFPuv .. s ... > 
GFPmyco .. s ... > 
150 160 170 180 190 
GFPwt YNS HNV YIM ADK QKN GIK VNF KIR HNI EOG SVQ LAD HYQ QNT PIG DGP 
GFPuv . . T A .. ... > 
GFPmyco .. T ... . . . A .. ... > 
200 210 220 230 
GFPwt VLL PON HYL STQ SAL SKD PNE KRD HMV LLE FVT AAG ITH GMO ELY K* 
GFPuv .> 
GFPmyco .> 
Figure 4. Comparison of the amino acid sequences of wild type GFP (GFPwt), GFPuv (a 
popular E. coli-optimized variant, Clontech), and the GFP sequence used for the GFPmyco 
gene. The amino acids are given as the single letter codes. Exact amino acid matches are shown 
as(.). Changes are indicated below the wild type sequence. 
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Figure 5. Comparison of the DNA gene sequences of GFPuv and GFPmyco. 162 base pair 
substitutions were necessary to convert the E. coli-optimized GFPuv sequence to the 
mycoplasma-optimized GFPmyco sequence. The translated amino acid sequence is shown 
above the corresponding DNA sequence. Homology is shown by(.). Base pair differences are 
shown in the GFPmyco sequence. 
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M s K G E E L F T G V V p I L V E L D G> 
10 20 30 40 50 60 
GFPuv ATG AGT AAA GGA GAA GAA CTT TTC ACT GGA GTT GTC CCA ATT CTT GTT GAA TTA GAT GGT 
GFPmyco .. T T.A .. T . . A .. T .. A .. A T.A •• • > 
D V N G H K F s V s G E G E G D A T y G> 
70 80 90 100 110 120 
GFPuv GAT GTT AAT GGG CAC AAA TTT TCT GTC AGT GGA GAG GGT GAA GGT GAT GCA ACA TAC GGA 
GFPmyco .. T . . T AG . .. A .. T .. A .. T .. T> 
K L T L K F I C T T G K L p V p w p T L> 
130 140 150 160 170 180 
GFPuv AAA CTT ACC CTT AAA TTT ATT TGC ACT ACT GGA AAA CTA CCT GTT CCA TGG CCA ACA CTT 
GFPmyco T.A .. AT.A .. T .. T T .. .. A .. A .. A .. T T.A> 
V T T F s y G V Q C F s R y p D H M K R> 
190 200 210 220 230 240 
GFPuv GTC ACT ACT TTC TCT TAT GGT GTT CAA TGC TTT TCC CGT TAT CCG GAT CAT ATG AAA CGG 
GFPmyco .. A .. A .. T GG. .. A .. T G.T A.A .. A .. c A.A> 
H D F F K s A M p E G y V Q E R T I s F> 
250 260 270 280 290 300 
GFPuv CAT GAC TTT TTC AAG AGT GCC ATG CCC GAA GGT TAT GTA CAG GAA CGC ACT ATA TCT TTC 
GFPmyco .. c .. T .. T . . A .. T .. A .. T .. A A . A .. A .. TAG . . . T> 
K D D G N y K T R A E V K F E G D T L V> 
310 320 330 340 350 360 
GFPuv AAA GAT GAC GGG AAC TAC AAG ACG CGT GCT GAA GTC AAG TTT GAA GGT GAT ACC CTT GTT 
GFPmyco .. T .. T .. T .. T .. A .. A A.A .. A .. A .. A .. T T.A .. A> 
N R I E L K G I D F K E D G N I L G H K> 
370 380 390 400 410 420 
GFPuv AAT CGT ATC GAG TTA AAA GGT ATT GAT TTT AAA GAA GAT GGA AAC ATT CTC GGA CAC AAA 
GFPmyco A.A .. T . . A .. T .. T T.A .. T .. T .•• > 
L E y N y N s H N V y I T A D K Q K N G> 
430 440 450 460 470 480 
GFPuv CTC GAG TAC AAC TAT AAC TCA CAC AAT GTA TAC ATC ACG GCA GAC AAA CAA AAG AAT GGA 
GFPmyco T.A .. A .. T .. T AGT .. T .. c .. T .. T .. T .. T .. T .. T .. A .. T> 
I K A N F K I R H N I E D G s V Q L A D> 
490 500 510 520 530 540 
GFPuv ATC AAA GCT AAC TTC AAA ATT CGC CAC AAC ATT GAA GAT GGA TCC GTT CAA CTA GCA GAC 
GFPmyco .. T .. T .. T A.A .. T .. T AGT T .. . .T> 
H y Q Q N T p I G D G p V L L p D N H Y> 
550 560 570 580 590 600 
GFPuv CAT TAT CAA CAA AAT ACT CCA ATT GGC GAT GGC CCT GTC CTT TTA CCA GAC AAC CAT TAC 
GFPmyco .. c .. T .. T .. A .. T T.A .. T .. T .. T> 
L s T Q s A L s K D p N E K R D H M V L> 
610 620 630 640 650 660 
GFPuv CTG TCG ACA CAA TCT GCC CTT TCG AAA GAT CCC AAC GAA AAG CGT GAC CAC ATG GTC CTT 
GFPmyco T.A AGT .. T AG . . . T T.A AGT .. A .. T .. A A.A .. T .. AT.A> 
L E F V T A A G I T H G M D E L y K *> 
670 680 690 700 710 
GFPuv CTT GAG TTT GTA ACT GCT GCT GGG ATT ACA CAT GGC ATG GAT GAG CTC TAC AAA TAA 
GFPmyco T.A .. A ... . . . . . . . . . . . . .. T . .. .. T .. c . . T .. . . .. . .AT.A .. T ... •.• > 
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Figure 6. Construction strategy for P2:GFPmyco. Two sets of overlapping oligomers, GFPl 
(5' end of the gene) and GFP2 (3' end of the gene) were used to assembly each half of the 
GFPmyco gene. Each set was slowly annealed, ligated, used as the templates in PCR reactions 
and cloned into pZERO as described in the text. Each half gene (gray bar and right hatched bar) 
was blunt-end digested with EcoRV, ligated to the other half and cloned into pSK to produce 
GFPmyco (pISM32). The GFPmyco gene was then PCR amplified with Pfu polymerase to 
create a 3' BamHI restriction site (and 5' blunt end). The P2 promoter sequence was PCR 
amplified in similar fashion to create a 5' BamHI restriction site (and 3' blunt end). The two 
fragments were ligated and then PCR amplified to create P2:GFPmyco. This PCR product was 
digested with BamHI and inserted into pISM2062 to create Tn400J:P2:GFPmyco. 
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EcoRV 
_,._,._,.:!I_._,. .. .. _._. .. 
....-~~.._.,_ ..... ~~ 
Mix oligos, denature, and renature 
EcoRV 
_,._,. _,.-+I_,._,._.,.,_.,.,~_,._,. .. 
++-+-+-4-4-+-.. 4 +-+-
Ligate and PCR to amplify the right product 
-~------ _ ..... .-c -__________ _ 
Clone into pZero2 and sequence 
BamHI EcoRV EcoRV Eco RI 
lw "T*twt1L- -VZ22272227272: 
Isolate fragments and reclone into pSK 
BamHI EcoRV EcoRI 
kw 1vn· kzzzz722ZZzzz:• 
+ PCR to create fragments for cloning 
P2 BamHI EcoRV EcoRI 
tssssssssssssssssssssss, _j!fillBt&zhtnkzzzzzzzzzzzzJ-
I A~2F A"$2R GiTmrF CM33R.B~m I 
BamHI + Digest and clone into plSM2062 BamHI 
BamHI EcoRV BamHI 
_jSSSSSSSSSSSSSSSSSSSSSSiiiii#liiM\ii%ffi~7ZZ7777777222J._ 
P2-----•~ GFPmyco 
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Figure 7. Mapping of oligonucleotides onto the GFPmyco gene sequence. Labeled arrows 
indicate location and orientation of each oligomer on the corresponding sequence. Bold arrows 
indicate PCR primers. The EcoRV assembly site is shown as a box. 
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CM14F 
ATGAGTAAAG;tAAGAATTATTTACAGGTGTAGTACCAATTTTAGTTGAATTAGATGGTGA 
CM3F 
... __ C~R- __ _ 
•-------
CM10R 
-----[> 
TGTTAATGGTCATAAATTTAGTGTAAGTGGTGAAGGTGAAGGTGATGCAACATATGGTAAATTAACATTA 
CM4F 
<]--~-M-~-0-~-.--------------•-----------r.> 
... _________ ~1..!_R _ _ 
AAATTTATTTGTACTACTGGTAAATTACCAGTACCATGACCAACTTTAGTAACAACTTTTGGTTATGGTG 
CM5F 
• 
•-----
CM12R 
... - -
TACAATGTTTTGCT GATAT CAGATCACATGAAAAGACACGATTTTTTTAAAAGTGCTATGCCAGAAGG 
CM6F 
-<l - - CM13R CM32F 
CM7Fb 
CM31R 
... 
CM30R 
TTATGTTCAAGAAAGAACAATTAGTTTTAAAGATGATGGTAATTATAAAACAAGAGCAGAAGTAAAATTT 
• CM8Fb 
--[> 
-<)----------
•- - - -
CM29R 
GAAGGTGATACTTTAGTAAATAGAATTGAATTAAAAGGTATTGATTTTAAAGAAGATGGTAATATTTTAG 
CM16F 
<:]-------
..------
CM28R 
- - - -
------t> 
GTCATAAATTAGAATATAATTATAACAGTCATAACGTTTATATTACTGCTGATAAACAAAAAAATGGTAT 
CM17F 
• 
~-----
..--------
CM27R 
TAAAGCTAATTTTAAAATTAGACATAACATTGAAGATGGTAGTGTTCAATTAGCAGATCACTATCAACAA 
CM18F 
• 
-<]-
•- - - -
•-
.... -
CM26R 
- - - -
AATACTCCAATTGGTGATGGTCCAGTTTTATTACCAGATAATCATTATTTAAGTACTCAAAGTGCTTTAA 
CM19F 
• CM20F 
<1- - - - - CM25R - - - -
GTAAAGATCCAAATGAAAAAAGAGATCACATGGTATTATTAGAATTTGTAACTGCTGCTGGTATTACTCA 
CM20F • 
CM21F 
-<]- - - - ... ___ ..QMZ,3fL __ 
CGGTATGGATGAATTATATAAATAAGAATTCGCTG 
• _____ C=M=2=2:....F ____ --1•9' 
<l -
• 
CM33R 
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Clones from the P2:GFPmcyo:pISM2062 ligation were examined for EcoRV restriction 
patterns. Some were partially sequenced to confirm the presence of the P2:GFPmyco fragment 
in the BamHl restriction site and to confirm the integrity of the P2:GFPmyco junction region. 
Plasmid pISM30 contains the P2:GFPmyco construct in Tn400Jmod (p1SM2062). 
Plasmid pISM30 caused weak fluorescence in E. coli. However no fluorescence was 
observed when it was used to transform M. gallisepticum. A number of factors may have 
contributed to these results. The low-level of GFPmyco fluorescence observed in E. coli could 
due to low protein levels and/or a marginally functional product. Inefficient opal suppressor 
activity in E. coli, which is required because of the UGA codon at position 171 in the GFPmyco 
sequence (Figure 5), would produce a truncated protein byproduct. Even a highly functional 
opal suppressor can be affected by multiple factors including the context of the UGA codon 
within the sequence (127). Alternatively, the codon usage frequencies could be effecting the 
translation rate. Many of the codons are extremely rare in E. coli, and the pools of charged 
tRNAs may be quickly depleted. 
One obvious explanation for the poor performance in both E. coli and mycoplasma is that 
GFPmyco is a particularly ineffective GFP variant. The translation product of the designed 
GFPmyco gene differed from that of the GFPuv parent by two amino acids. Although either is 
located in the chromophore and the alternate amino acids have been found in other highly 
functional GFP mutants, it is possible that the new sequence introduced a deleterious intra-
protein interaction. This could have effected folding, chromophore excitation or fluorescence. 
One factor not taken into account in the mycoplasma expression studies was the impact of 
the media environment on fluorescence. It is well known that changes in pH, salt concentration, 
etc. affect GFP folding (29, 90). For example, toxic effects have been associated with high 
media salt concentration in Helicobacter species (72). The highly enriched mycoplasma 
medium is quite different from the standard E. coli media. One obvious difference is that 
mycoplasma media is titrated to an initial pH of 7.8 as opposed to the 7.3-7.4 for E.coli media. 
Potentially even more problematic are the media supplements. Yeast extract, horse serum and 
even Cefobid could inhibit GFP folding or chromophore activity. It would be interesting to see 
the effect of these factors on GFP fluorescence levels in E. coli. 
It is less likely that the lack of GFP expression in mycoplasma is a temperature effect. 
Although GFP folds relatively poorly at 37°C (142), GFPuv grown at 37°C can still be 
observed by the naked eye. However temperature effects cannot be excluded completely. 
Different GFP variants have different temperature sensitivities as well as sensitivities to media 
components (72, 74). It is possible that the increased temperature in combination with reduced 
pH, for example, could prevent the formation of a necessary folding intermediate. 
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Although GFP has generally been considered nontoxic even in large concentrations, this is 
not always the case. In 1995, Davis et al. reported that GFP effected cell growth (27). More 
recently, Liu et al. demonstrated a link between GFP expression and induction of apoptosis in 
several eukaryotic cell lines (81 ). Studies of GFP labeled retroviruses had previously shown 
that producer cells expressing high levels of GFP appeared to be at a selective disadvantage 
(59). Similar apparent GFP concentration maxima have also been observed in plant cells (121). 
Since mycoplasmas are in general much more fragile than E. coli, a minor toxic effect in E. coli 
might be almost completely lethal in mycoplasma cells expressing GFP. This effect could have 
been accentuated by the use of P2, an extremely strong mycoplasma promoter for the 
mycoplasma expression studies. 
Another factor that must be considered is the ( currently unknown) orientation of the P2GFP 
construct in the host plasmid. P2 is a strong promoter but pISM2062 has promoters of its own. 
The production of antisense RNA could certainly reduce the amount of protein product. 
It is also possible that protein degradation may have effected either protein levels or 
apparent fluorescence. GFP is normally an extremely very stable protein. Both 5' and 3' GFP 
fusion proteins are commonly used for protein expression or interaction studies. However, it 
can be destabilized by the addition of a protease sensitive tail sequence (3) The original 
construct had an error in its stop codon. This should not have effected folding or fluorescence 
as the last 9 amino acids of the gene are expendable. It is theoretically possible, however, that 
the run-on tail may have accidentally duplicated a protease-sensitive sequence. The result would 
be a reduced GFP half-life and a correspondingly reduced fluorescent signal. Because the 
(weak) signal observed in E.coli was quite stable, this is unlikely to be a primary cause of 
reduced fluorescence but it may be a minor contributing factor. 
Finally the basic premise of the sequence design itself might be flawed. It was based on 
codon usage frequency data since detailed tRNA analysis and/or translation efficiencies are 
unavailable for most mycoplasma species, including M. gallisepticum. It is already known that 
codon usage frequencies differ from mycoplasma to mycoplasma. So do the number of tRNAs 
and their arrangement on the genome (111). It may be that the synthetic sequence, which was 
derived from multi-species consensus codon usage data, is not easily processed by the M. 
gallisepticum translational machinery. 
It is obvious that work has only begun on the development of a mycoplasma-specific GFP 
variant. Media and sequence change effects will be easy to isolate. Other factors will be harder 
to eliminate. There is still a great need for an easily visualized, individual cell, in vivo 
mycoplasma label. More important, the development of this marker may provide interesting and 
useful information about both mycoplasma cellular activity and GFP functions. 
50 
CONCLUSIONS 
The goal of this project was to design and assemble two genetic tools for use in 
mycoplasmas. The first tool was a mini-transposon for the easy delivery of a variety of markers 
to the mycoplasma chromosome. The second tool was a mycoplasma-specific GFP marker that 
would allow easy visualization of individual cells, organelles or proteins. The resulting mini-
Tn4001 does function relatively efficiently in M gallisepticum. Unfortunately, the mycoplasma-
specific GFPmyco construct failed to give a useful signal in preliminary expression studies for 
undetermined reasons. 
There are several potential applications for the miniTn4001. The tetM gene was inserted into 
the mini-Tn4001 cloning site for these studies, but other markers could also be used. The next 
step will be the insertion of alternative antibiotic resistance markers and hopefully a cell 
visualization signal (such as GFP) for use in studies of mycoplasma virulence. 
The GFPmyco construct must be considered still under development. Work is currently 
underway to express the gene from a different promoter. Site-directed mutagenesis could be 
used to modify the GFPmyco gene sequence so that the amino sequence of the protein 
produced is identical to a known high signal GFP mutant. Additional experiments such as 
assessing the effect of mycoplasma media supplements on the fluorescence level of well-studied 
GFP variants could provide useful information about both GFP expression levels in 
mycoplasma and basic GFP biochemistry. 
Historically mycoplasma research has lagged due to the technical difficulties of genetic 
manipulations and lack of suitable biological tools. Hopefully the constructs described here will 
help bridge this gap. 
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